ONTOLOGY REPORT - ANNOTATIONS
|
|||||||||||||||||||||||||||||||
valproic acid
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ABHD17A | abhydrolase domain containing 17A |
|
affects expression | ISO | 19 | 1,876,975 | 1,885,518 | RGD:6480464 | CTD | |
| G | ABHD17C | abhydrolase domain containing 17C |
|
affects expression | ISO | 15 | 80,987,652 | 81,047,962 | RGD:6480464 | CTD | |
| G | C12orf4 | chromosome 12 open reading frame 4 |
|
affects expression | ISO | 12 | 4,596,901 | 4,647,637 | RGD:6480464 | CTD | |
| G | C12orf45 | chromosome 12 open reading frame 45 |
|
affects expression | ISO | 12 | 105,380,098 | 105,388,505 | RGD:6480464 | CTD | |
| G | C5orf30 | chromosome 5 open reading frame 30 |
|
affects expression | ISO | 5 | 102,594,442 | 102,614,361 | RGD:6480464 | CTD | |
| G | CD63 | CD63 molecule |
|
increases expression | EXP | 12 | 56,119,227 | 56,123,457 | RGD:6480464 | CTD | |
| G | CD63 | CD63 molecule |
|
multiple interactions | EXP | 12 | 56,119,227 | 56,123,457 | RGD:6480464 | CTD | |
| G | CD80 | CD80 molecule |
|
affects expression | ISO | 3 | 119,243,140 | 119,278,481 | RGD:6480464 | CTD | |
| G | CD83 | CD83 molecule |
|
increases expression | EXP | 6 | 14,117,487 | 14,137,149 | RGD:6480464 | CTD | |
| G | CD9 | CD9 molecule |
|
increases expression | EXP | 12 | 6,309,482 | 6,347,437 | RGD:6480464 | CTD | |
| G | CD96 | CD96 molecule |
|
affects expression | ISO | 3 | 111,260,926 | 111,371,206 | RGD:6480464 | CTD | |
| G | CD99 | CD99 molecule |
|
increases expression | EXP | X Y |
2,609,228 2,559,228 |
2,659,350 2,609,350 |
RGD:6480464 | CTD | |
| G | CDADC1 | cytidine and dCMP deaminase domain containing 1 |
|
multiple interactions | EXP | 13 | 49,822,047 | 49,867,622 | RGD:6480464 | CTD | |
| G | CDC14B | cell division cycle 14B |
|
affects expression | ISO | 9 | 99,262,395 | 99,382,112 | RGD:6480464 | CTD | |
| G | CDC20 | cell division cycle 20 |
|
affects expression | ISO | 1 | 43,824,626 | 43,828,874 | RGD:6480464 | CTD | |
| G | CDC25A | cell division cycle 25A |
|
affects expression | ISO | 3 | 48,198,668 | 48,229,801 | RGD:6480464 | CTD | |
| G | CDC26 | cell division cycle 26 |
|
affects expression | ISO | 9 | 116,029,288 | 116,037,869 | RGD:6480464 | CTD | |
| G | CDC27 | cell division cycle 27 |
|
decreases expression | ISO | 17 | 45,195,310 | 45,266,665 | RGD:6480464 | CTD | |
| G | CDC37 | cell division cycle 37 |
|
multiple interactions | EXP | 19 | 10,501,809 | 10,514,271 | RGD:6480464 | CTD | |
| G | CDC40 | cell division cycle 40 |
|
affects expression | ISO | 6 | 110,501,624 | 110,553,423 | RGD:6480464 | CTD | |
| G | CDC42 | cell division cycle 42 |
|
multiple interactions | EXP | 1 | 22,379,120 | 22,419,436 | RGD:6480464 | CTD | |
| G | CDC42EP2 | CDC42 effector protein (Rho GTPase binding) 2 |
|
increases expression | ISO | 11 | 65,082,289 | 65,089,900 | RGD:6480464 | CTD | |
| G | CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 |
|
affects expression | ISO | 2 | 37,869,025 | 37,899,678 | RGD:6480464 | CTD | |
| G | CDC42EP4 | CDC42 effector protein (Rho GTPase binding) 4 |
|
affects expression | ISO | 17 | 71,279,763 | 71,308,143 | RGD:6480464 | CTD | |
| G | CDC42EP5 | CDC42 effector protein (Rho GTPase binding) 5 |
|
increases expression | EXP | 19 | 54,976,210 | 54,984,422 | RGD:6480464 | CTD | |
| G | CDC42EP5 | CDC42 effector protein (Rho GTPase binding) 5 |
|
affects expression | ISO | 19 | 54,976,210 | 54,984,422 | RGD:6480464 | CTD | |
| G | CDC42SE1 | CDC42 small effector 1 |
|
affects expression | ISO | 1 | 151,023,447 | 151,032,125 | RGD:6480464 | CTD | |
| G | CDC42SE1 | CDC42 small effector 1 |
|
decreases expression | ISO | 1 | 151,023,447 | 151,032,125 | RGD:6480464 | CTD | |
| G | CDC6 | cell division cycle 6 |
|
affects expression | ISO | 17 | 38,444,146 | 38,459,413 | RGD:6480464 | CTD | |
| G | CDC73 | cell division cycle 73 |
|
affects expression | ISO | 1 | 193,091,088 | 193,223,945 | RGD:6480464 | CTD | |
| G | CDCA4 | cell division cycle associated 4 |
|
affects expression | ISO | 14 | 105,475,910 | 105,487,425 | RGD:6480464 | CTD | |
| G | CDCA5 | cell division cycle associated 5 |
|
decreases expression | EXP | 11 | 64,844,927 | 64,851,615 | RGD:6480464 | CTD | |
| G | CDCA5 | cell division cycle associated 5 |
|
decreases expression | ISO | 11 | 64,844,927 | 64,851,615 | RGD:6480464 | CTD | |
| G | CDCA7 | cell division cycle associated 7 |
|
affects expression | ISO | 2 | 174,219,561 | 174,233,718 | RGD:6480464 | CTD | |
| G | CDCA7 | cell division cycle associated 7 |
|
decreases expression | ISO | 2 | 174,219,561 | 174,233,718 | RGD:6480464 | CTD | |
| G | CDH1 | cadherin 1, type 1, E-cadherin (epithelial) |
|
increases expression | EXP | 16 | 68,771,195 | 68,869,444 | RGD:6480464 | CTD | |
| G | CDH1 | cadherin 1, type 1, E-cadherin (epithelial) |
|
affects expression | ISO | 16 | 68,771,195 | 68,869,444 | RGD:6480464 | CTD | |
| G | CDH1 | cadherin 1, type 1, E-cadherin (epithelial) |
|
increases expression | ISO | 16 | 68,771,195 | 68,869,444 | RGD:6480464 | CTD | |
| G | CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) |
|
increases expression | EXP | 16 | 64,980,683 | 65,155,919 | RGD:6480464 | CTD | |
| G | CDK12 | cyclin-dependent kinase 12 |
|
multiple interactions | EXP | 17 | 37,617,739 | 37,690,800 | RGD:6480464 | CTD | |
| G | CDK12 | cyclin-dependent kinase 12 |
|
affects expression | ISO | 17 | 37,617,739 | 37,690,800 | RGD:6480464 | CTD | |
| G | CDK16 | cyclin-dependent kinase 16 |
|
increases expression | ISO | X | 47,077,528 | 47,089,396 | RGD:6480464 | CTD | |
| G | CHMP4C | charged multivesicular body protein 4C |
|
affects expression | ISO | 8 | 82,644,688 | 82,671,750 | RGD:6480464 | CTD | |
| G | CHMP5 | charged multivesicular body protein 5 |
|
multiple interactions | EXP | 9 | 33,264,877 | 33,282,067 | RGD:6480464 | CTD | |
| G | CHN2 | chimerin 2 |
|
multiple interactions | EXP | 7 | 29,234,121 | 29,553,944 | RGD:6480464 | CTD | |
| G | CHN2 | chimerin 2 |
|
affects expression | ISO | 7 | 29,234,121 | 29,553,944 | RGD:6480464 | CTD | |
| G | CHODL | chondrolectin |
|
affects expression | ISO | 21 | 19,400,190 | 19,639,687 | RGD:6480464 | CTD | |
| G | CHORDC1 | cysteine and histidine-rich domain (CHORD) containing 1 |
|
affects expression | ISO | 11 | 89,933,597 | 89,956,532 | RGD:6480464 | CTD | |
| G | CHPT1 | choline phosphotransferase 1 |
|
increases expression | EXP | 12 | 102,091,417 | 102,122,846 | RGD:6480464 | CTD | |
| G | CHPT1 | choline phosphotransferase 1 |
|
affects expression | ISO | 12 | 102,091,417 | 102,122,846 | RGD:6480464 | CTD | |
| G | CHRD | chordin |
|
affects expression | ISO | 3 | 184,097,861 | 184,107,617 | RGD:6480464 | CTD | |
| G | CHRNA1 | cholinergic receptor, nicotinic, alpha 1 (muscle) |
|
multiple interactions | EXP | 2 | 175,612,320 | 175,629,200 | RGD:6480464 | CTD | |
| G | CHRNA10 | cholinergic receptor, nicotinic, alpha 10 (neuronal) |
|
affects expression | ISO | 11 | 3,686,817 | 3,692,614 | RGD:6480464 | CTD | |
| G | CHRNA4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
affects expression | ISO | 20 | 61,974,662 | 61,992,748 | RGD:6480464 | CTD | |
| G | CHRNA9 | cholinergic receptor, nicotinic, alpha 9 (neuronal) |
|
affects expression | ISO | 4 | 40,337,346 | 40,357,234 | RGD:6480464 | CTD | |
| G | CHRNB4 | cholinergic receptor, nicotinic, beta 4 (neuronal) |
|
increases expression | ISO | 15 | 78,916,636 | 78,933,587 | RGD:6480464 | CTD | |
| G | CHST1 | carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
|
increases expression | EXP | 11 | 45,669,239 | 45,687,206 | RGD:6480464 | CTD | |
| G | CHST13 | carbohydrate (chondroitin 4) sulfotransferase 13 |
|
multiple interactions | EXP | 3 | 126,243,131 | 126,262,134 | RGD:6480464 | CTD | |
| G | CHST15 | carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
|
increases expression | EXP | 10 | 125,767,182 | 125,853,123 | RGD:6480464 | CTD | |
| G | CIAO1 | cytosolic iron-sulfur protein assembly 1 |
|
affects expression | ISO | 2 | 96,931,884 | 96,939,917 | RGD:6480464 | CTD | |
| G | CIB1 | calcium and integrin binding 1 (calmyrin) |
|
multiple interactions | EXP | 15 | 90,773,477 | 90,777,279 | RGD:6480464 | CTD | |
| G | CIB1 | calcium and integrin binding 1 (calmyrin) |
|
affects expression | ISO | 15 | 90,773,477 | 90,777,279 | RGD:6480464 | CTD | |
| G | CIB1 | calcium and integrin binding 1 (calmyrin) |
|
increases expression | EXP | 15 | 90,773,477 | 90,777,279 | RGD:6480464 | CTD | |
| G | CIB1 | calcium and integrin binding 1 (calmyrin) |
|
increases expression | ISO | 15 | 90,773,477 | 90,777,279 | RGD:6480464 | CTD | |
| G | CIB2 | calcium and integrin binding family member 2 |
|
affects expression | ISO | 15 | 78,396,991 | 78,423,878 | RGD:6480464 | CTD | |
| G | CIB2 | calcium and integrin binding family member 2 |
|
increases expression | ISO | 15 | 78,396,991 | 78,423,878 | RGD:6480464 | CTD | |
| G | CIC | capicua transcriptional repressor |
|
affects expression | ISO | 19 | 42,788,817 | 42,799,949 | RGD:6480464 | CTD | |
| G | CIRH1A | cirrhosis, autosomal recessive 1A (cirhin) |
|
affects expression | ISO | 16 | 69,166,499 | 69,202,937 | RGD:6480464 | CTD | |
| G | CISD1 | CDGSH iron sulfur domain 1 |
|
affects expression | ISO | 10 | 60,028,862 | 60,049,019 | RGD:6480464 | CTD | |
| G | CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
affects expression | ISO | 6 | 139,693,392 | 139,695,787 | RGD:6480464 | CTD | |
| G | CITED4 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
|
affects expression | ISO | 1 | 41,326,728 | 41,328,018 | RGD:6480464 | CTD | |
| G | CITED4 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
|
increases expression | ISO | 1 | 41,326,728 | 41,328,018 | RGD:6480464 | CTD | |
| G | CKB | creatine kinase, brain |
|
increases expression | EXP | 14 | 103,985,995 | 103,989,196 | RGD:6480464 | CTD | |
| G | CKB | creatine kinase, brain |
|
affects expression | ISO | 14 | 103,985,995 | 103,989,196 | RGD:6480464 | CTD | |
| G | CKLF | chemokine-like factor |
|
increases expression | ISO | 16 | 66,586,466 | 66,600,190 | RGD:6480464 | CTD | |
| G | CKMT1B | creatine kinase, mitochondrial 1B |
|
affects expression | ISO | 15 | 43,885,252 | 43,891,604 | RGD:6480464 | CTD | |
| G | CLASP2 | cytoplasmic linker associated protein 2 |
|
multiple interactions | EXP | 3 | 33,537,737 | 33,759,705 | RGD:6480464 | CTD | |
| G | CLCC1 | chloride channel CLIC-like 1 |
|
affects expression | ISO | 1 | 109,472,130 | 109,506,111 | RGD:6480464 | CTD | |
| G | CLCN5 | chloride channel, voltage-sensitive 5 |
|
multiple interactions | EXP | X | 49,687,225 | 49,863,892 | RGD:6480464 | CTD | |
| G | CLCNKB | chloride channel, voltage-sensitive Kb |
|
affects expression | ISO | 1 | 16,370,231 | 16,383,821 | RGD:6480464 | CTD | |
| G | CLDN14 | claudin 14 |
|
affects expression | ISO | 21 | 37,832,919 | 37,948,867 | RGD:6480464 | CTD | |
| G | CLDN16 | claudin 16 |
|
affects expression | ISO | 3 | 190,105,661 | 190,129,932 | RGD:6480464 | CTD | |
| G | CLDN2 | claudin 2 |
|
affects expression | ISO | X | 106,143,394 | 106,174,091 | RGD:6480464 | CTD | |
| G | CLDND2 | claudin domain containing 2 |
|
affects expression | ISO | 19 | 51,870,352 | 51,872,257 | RGD:6480464 | CTD | |
| G | CLEC16A | C-type lectin domain family 16, member A |
|
affects expression | ISO | 16 | 11,038,345 | 11,276,046 | RGD:6480464 | CTD | |
| G | CLEC1A | C-type lectin domain family 1, member A |
|
affects expression | ISO | 12 | 10,223,080 | 10,251,605 | RGD:6480464 | CTD | |
| G | CLEC2D | C-type lectin domain family 2, member D |
|
affects expression | ISO | 12 | 9,822,304 | 9,852,151 | RGD:6480464 | CTD | |
| G | CLEC4E | C-type lectin domain family 4, member E |
|
affects expression | ISO | 12 | 8,685,901 | 8,693,558 | RGD:6480464 | CTD | |
| G | CLIC1 | chloride intracellular channel 1 |
|
affects expression | ISO | 6 | 31,698,358 | 31,704,341 | RGD:6480464 | CTD | |
| G | CLIC6 | chloride intracellular channel 6 |
|
increases expression | ISO | 21 | 36,041,688 | 36,090,519 | RGD:6480464 | CTD | |
| G | CLIP4 | CAP-GLY domain containing linker protein family, member 4 |
|
affects expression | ISO | 2 | 29,338,308 | 29,406,679 | RGD:6480464 | CTD | |
| G | CLK1 | CDC-like kinase 1 |
|
affects expression | ISO | 2 | 201,717,732 | 201,729,467 | RGD:6480464 | CTD | |
| G | CLK4 | CDC-like kinase 4 |
|
decreases expression | ISO | 5 | 178,029,665 | 178,054,054 | RGD:6480464 | CTD | |
| G | CLMN | calmin (calponin-like, transmembrane) |
|
increases expression | EXP | 14 | 95,648,276 | 95,786,245 | RGD:6480464 | CTD | |
| G | CLMP | CXADR-like membrane protein |
|
decreases expression | EXP | 11 | 122,943,020 | 123,066,007 | RGD:6480464 | CTD | |
| G | CLN8 | ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) |
|
increases expression | EXP | 8 | 1,711,870 | 1,734,736 | RGD:6480464 | CTD | |
| G | CLPX | ClpX caseinolytic peptidase X homolog (E. coli) |
|
affects expression | ISO | 15 | 65,442,784 | 65,477,563 | RGD:6480464 | CTD | |
| G | CLTB | clathrin, light chain B |
|
affects expression | ISO | 5 | 175,819,456 | 175,843,570 | RGD:6480464 | CTD | |
| G | CLYBL | citrate lyase beta like |
|
multiple interactions | EXP | 13 | 100,258,919 | 100,549,388 | RGD:6480464 | CTD | |
| G | CLYBL | citrate lyase beta like |
|
increases expression | EXP | 13 | 100,258,919 | 100,549,388 | RGD:6480464 | CTD | |
| G | CLYBL | citrate lyase beta like |
|
affects expression | ISO | 13 | 100,258,919 | 100,549,388 | RGD:6480464 | CTD | |
| G | CMTM8 | CKLF-like MARVEL transmembrane domain containing 8 |
|
affects expression | ISO | 3 | 32,280,171 | 32,411,813 | RGD:6480464 | CTD | |
| G | CNGB1 | cyclic nucleotide gated channel beta 1 |
|
affects expression | ISO | 16 | 57,916,244 | 58,005,020 | RGD:6480464 | CTD | |
| G | CREB1 | cAMP responsive element binding protein 1 |
|
increases expression | ISO | 2 | 208,394,616 | 208,470,284 | RGD:6480464 | CTD | |
| G | CREB1 | cAMP responsive element binding protein 1 |
|
multiple interactions | EXP | 2 | 208,394,616 | 208,470,284 | RGD:6480464 | CTD | |
| G | CREB1 | cAMP responsive element binding protein 1 |
|
multiple interactions | ISO | 2 | 208,394,616 | 208,470,284 | RGD:6480464 | CTD | |
| G | CREB3 | cAMP responsive element binding protein 3 |
|
affects expression | ISO | 9 | 35,732,317 | 35,737,005 | RGD:6480464 | CTD | |
| G | CREB3L1 | cAMP responsive element binding protein 3-like 1 |
|
increases expression | ISO | 11 | 46,299,228 | 46,342,972 | RGD:6480464 | CTD | |
| G | CREB3L3 | cAMP responsive element binding protein 3-like 3 |
|
affects expression | ISO | 19 | 4,153,629 | 4,173,048 | RGD:6480464 | CTD | |
| G | CREB3L4 | cAMP responsive element binding protein 3-like 4 |
|
affects expression | ISO | 1 | 153,940,315 | 153,946,840 | RGD:6480464 | CTD | |
| G | CREB3L4 | cAMP responsive element binding protein 3-like 4 |
|
increases expression | ISO | 1 | 153,940,315 | 153,946,840 | RGD:6480464 | CTD | |
| G | CREB5 | cAMP responsive element binding protein 5 |
|
multiple interactions | EXP | 7 | 28,338,940 | 28,865,511 | RGD:6480464 | CTD | |
| G | CREBBP | CREB binding protein |
|
decreases expression | EXP | 16 | 3,775,055 | 3,930,121 | RGD:6480464 | CTD | |
| G | CREBZF | CREB/ATF bZIP transcription factor |
|
decreases expression | ISO | 11 | 85,368,608 | 85,376,182 | RGD:6480464 | CTD | |
| G | CREG1 | cellular repressor of E1A-stimulated genes 1 |
|
increases expression | EXP | 1 | 167,510,250 | 167,523,056 | RGD:6480464 | CTD | |
| G | CREG1 | cellular repressor of E1A-stimulated genes 1 |
|
increases expression | ISO | 1 | 167,510,250 | 167,523,056 | RGD:6480464 | CTD | |
| G | CRELD1 | cysteine-rich with EGF-like domains 1 |
|
affects expression | ISO | 3 | 9,975,524 | 9,987,097 | RGD:6480464 | CTD | |
| G | CRELD2 | cysteine-rich with EGF-like domains 2 |
|
affects expression | ISO | 22 | 50,312,283 | 50,321,186 | RGD:6480464 | CTD | |
| G | CRIP1 | cysteine-rich protein 1 (intestinal) |
|
increases expression | ISO | 14 | 105,953,257 | 105,955,126 | RGD:6480464 | CTD | |
| G | CRIP2 | cysteine-rich protein 2 |
|
affects expression | ISO | 14 | 105,939,275 | 105,946,507 | RGD:6480464 | CTD | |
| G | CRIPT | cysteine-rich PDZ-binding protein |
|
affects expression | ISO | 2 | 46,844,325 | 46,852,881 | RGD:6480464 | CTD | |
| G | CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
affects expression | ISO | 22 | 21,271,714 | 21,308,037 | RGD:6480464 | CTD | |
| G | CRLF1 | cytokine receptor-like factor 1 |
|
affects expression | ISO | 19 | 18,704,035 | 18,717,660 | RGD:6480464 | CTD | |
| G | CRMP1 | collapsin response mediator protein 1 |
|
affects expression | ISO | 4 | 5,822,491 | 5,894,785 | RGD:6480464 | CTD | |
| G | CRNKL1 | crooked neck pre-mRNA splicing factor-like 1 (Drosophila) |
|
affects expression | ISO | 20 | 20,015,012 | 20,036,690 | RGD:6480464 | CTD | |
| G | CROCC | ciliary rootlet coiled-coil, rootletin |
|
affects expression | ISO | 1 | 17,248,445 | 17,299,474 | RGD:6480464 | CTD | |
| G | CROT | carnitine O-octanoyltransferase |
|
affects expression | ISO | 7 | 86,974,951 | 87,029,112 | RGD:6480464 | CTD | |
| G | CRTC3 | CREB regulated transcription coactivator 3 |
|
affects expression | ISO | 15 | 91,073,118 | 91,188,577 | RGD:6480464 | CTD | |
| G | CRYAA | crystallin, alpha A |
|
affects expression | ISO | 21 | 44,589,141 | 44,592,913 | RGD:6480464 | CTD | |
| G | CRYAB | crystallin, alpha B |
|
decreases expression | ISO | 11 | 111,779,350 | 111,782,473 | RGD:6480464 | CTD | |
| G | CRYBA2 | crystallin, beta A2 |
|
affects expression | ISO | 2 | 219,854,912 | 219,858,127 | RGD:6480464 | CTD | |
| G | CRYBA4 | crystallin, beta A4 |
|
multiple interactions | EXP | 22 | 27,017,928 | 27,026,636 | RGD:6480464 | CTD | |
| G | CRYGA | crystallin, gamma A |
|
affects expression | ISO | 2 | 209,025,464 | 209,028,297 | RGD:6480464 | CTD | |
| G | CRYGS | crystallin, gamma S |
|
affects expression | ISO | 3 | 186,256,232 | 186,262,167 | RGD:6480464 | CTD | |
| G | CRYL1 | crystallin, lambda 1 |
|
affects expression | ISO | 13 | 20,977,806 | 21,100,012 | RGD:6480464 | CTD | |
| G | CRYM | crystallin, mu |
|
increases expression | EXP | 16 | 21,269,839 | 21,314,404 | RGD:6480464 | CTD | |
| G | CRYZ | crystallin, zeta (quinone reductase) |
|
increases expression | EXP | 1 | 75,171,170 | 75,199,092 | RGD:6480464 | CTD | |
| G | CSAD | cysteine sulfinic acid decarboxylase |
|
affects expression | ISO | 12 | 53,551,447 | 53,574,693 | RGD:6480464 | CTD | |
| G | CSE1L | CSE1 chromosome segregation 1-like (yeast) |
|
affects expression | ISO | 20 | 47,662,783 | 47,713,497 | RGD:6480464 | CTD | |
| G | CSF3 | colony stimulating factor 3 (granulocyte) |
|
affects expression | ISO | 17 | 38,171,614 | 38,174,066 | RGD:6480464 | CTD | |
| G | CSF3R | colony stimulating factor 3 receptor (granulocyte) |
|
affects expression | ISO | 1 | 36,931,644 | 36,948,915 | RGD:6480464 | CTD | |
| G | CSMD2 | CUB and Sushi multiple domains 2 |
|
affects expression | ISO | 1 | 33,979,609 | 34,631,443 | RGD:6480464 | CTD | |
| G | CSNK1D | casein kinase 1, delta |
|
affects expression | ISO | 17 | 80,200,537 | 80,231,594 | RGD:6480464 | CTD | |
| G | CSNK1D | casein kinase 1, delta |
|
decreases expression | ISO | 17 | 80,200,537 | 80,231,594 | RGD:6480464 | CTD | |
| G | CSNK1G2 | casein kinase 1, gamma 2 |
|
affects expression | ISO | 19 | 1,941,161 | 1,981,337 | RGD:6480464 | CTD | |
| G | CSNK2A1 | casein kinase 2, alpha 1 polypeptide |
|
decreases expression | ISO | 20 | 463,338 | 524,482 | RGD:6480464 | CTD | |
| G | CSRNP2 | cysteine-serine-rich nuclear protein 2 |
|
increases expression | ISO | 12 | 51,454,988 | 51,477,454 | RGD:6480464 | CTD | |
| G | CST4 | cystatin S |
|
multiple interactions | EXP | 20 | 23,666,277 | 23,669,662 | RGD:6480464 | CTD | |
| G | CST5 | cystatin D |
|
affects expression | ISO | 20 | 23,856,572 | 23,860,380 | RGD:6480464 | CTD | |
| G | CST8 | cystatin 8 (cystatin-related epididymal specific) |
|
affects expression | ISO | 20 | 23,471,766 | 23,476,655 | RGD:6480464 | CTD | |
| G | CSTF1 | cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kDa |
|
decreases expression | ISO | 20 | 54,967,427 | 54,979,582 | RGD:6480464 | CTD | |
| G | CSTF2 | cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa |
|
decreases expression | ISO | X | 100,075,348 | 100,095,924 | RGD:6480464 | CTD | |
| G | CSTF3 | cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDa |
|
affects expression | ISO | 11 | 33,106,130 | 33,183,037 | RGD:6480464 | CTD | |
| G | CTAG1B | cancer/testis antigen 1B |
|
multiple interactions | EXP | X | 153,845,865 | 153,847,522 | RGD:6480464 | CTD | |
| G | CTCF | CCCTC-binding factor (zinc finger protein) |
|
multiple interactions | EXP | 16 | 67,596,310 | 67,673,088 | RGD:6480464 | CTD | |
| G | CTCF | CCCTC-binding factor (zinc finger protein) |
|
decreases expression | ISO | 16 | 67,596,310 | 67,673,088 | RGD:6480464 | CTD | |
| G | CTDSP2 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
|
affects expression | ISO | 12 | 58,213,710 | 58,240,747 | RGD:6480464 | CTD | |
| G | CTGF | connective tissue growth factor |
|
affects expression | ISO | 6 | 132,269,316 | 132,272,518 | RGD:6480464 | CTD | |
| G | CTHRC1 | collagen triple helix repeat containing 1 |
|
increases expression | EXP | 8 | 104,383,743 | 104,395,233 | RGD:6480464 | CTD | |
| G | CTHRC1 | collagen triple helix repeat containing 1 |
|
increases expression | ISO | 8 | 104,383,743 | 104,395,233 | RGD:6480464 | CTD | |
| G | CTIF | CBP80/20-dependent translation initiation factor |
|
affects expression | ISO | 18 | 46,065,427 | 46,389,588 | RGD:6480464 | CTD | |
| G | CTIF | CBP80/20-dependent translation initiation factor |
|
increases expression | ISO | 18 | 46,065,427 | 46,389,588 | RGD:6480464 | CTD | |
| G | CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa |
|
increases expression | ISO | 3 | 41,240,942 | 41,281,939 | RGD:6480464 | CTD | |
| G | CTNNBIP1 | catenin, beta interacting protein 1 |
|
decreases expression | ISO | 1 | 9,908,334 | 9,970,316 | RGD:6480464 | CTD | |
| G | CTNND1 | catenin (cadherin-associated protein), delta 1 |
|
multiple interactions | EXP | 11 | 57,529,234 | 57,586,652 | RGD:6480464 | CTD | |
| G | CTNS | cystinosin, lysosomal cystine transporter |
|
increases expression | ISO | 17 | 3,539,762 | 3,566,397 | RGD:6480464 | CTD | |
| G | CYP2U1 | cytochrome P450, family 2, subfamily U, polypeptide 1 |
|
affects expression | ISO | 4 | 108,852,717 | 108,874,613 | RGD:6480464 | CTD | |
| G | CYP39A1 | cytochrome P450, family 39, subfamily A, polypeptide 1 |
|
affects expression | ISO | 6 | 46,517,445 | 46,620,523 | RGD:6480464 | CTD | |
| G | CYP46A1 | cytochrome P450, family 46, subfamily A, polypeptide 1 |
|
increases expression | ISO | 14 | 100,150,755 | 100,193,638 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
decreases expression | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
increases expression | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
affects expression | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A22 | cytochrome P450, family 4, subfamily A, polypeptide 22 |
|
increases expression | ISO | 1 | 47,603,107 | 47,614,526 | RGD:6480464 | CTD | |
| G | CYP4X1 | cytochrome P450, family 4, subfamily X, polypeptide 1 |
|
multiple interactions | EXP | 1 | 47,489,240 | 47,516,423 | RGD:6480464 | CTD | |
| G | CYP4Z1 | cytochrome P450, family 4, subfamily Z, polypeptide 1 |
|
multiple interactions | EXP | 1 | 47,533,160 | 47,583,992 | RGD:6480464 | CTD | |
| G | CYP51A1 | cytochrome P450, family 51, subfamily A, polypeptide 1 |
|
affects expression | ISO | 7 | 91,741,463 | 91,764,059 | RGD:6480464 | CTD | |
| G | CYR61 | cysteine-rich, angiogenic inducer, 61 |
|
affects expression | ISO | 1 | 86,046,444 | 86,049,650 | RGD:6480464 | CTD | |
| G | CYS1 | cystin 1 |
|
affects expression | ISO | 2 | 10,196,926 | 10,220,538 | RGD:6480464 | CTD | |
| G | CYSLTR1 | cysteinyl leukotriene receptor 1 |
|
decreases expression | ISO | X | 77,528,130 | 77,583,087 | RGD:6480464 | CTD | |
| G | CYSTM1 | cysteine-rich transmembrane module containing 1 |
|
increases expression | EXP | 5 | 139,554,653 | 139,623,374 | RGD:6480464 | CTD | |
| G | DAAM1 | dishevelled associated activator of morphogenesis 1 |
|
increases expression | EXP | 14 | 59,655,381 | 59,838,123 | RGD:6480464 | CTD | |
| G | DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) |
|
decreases expression | ISO | 1 | 57,463,579 | 58,716,211 | RGD:6480464 | CTD | |
| G | DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) |
|
affects expression | ISO | 1 | 57,463,579 | 58,716,211 | RGD:6480464 | CTD | |
| G | DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) |
|
increases expression | ISO | 1 | 57,463,579 | 58,716,211 | RGD:6480464 | CTD | |
| G | DAB2IP | DAB2 interacting protein |
|
affects expression | ISO | 9 | 124,329,399 | 124,547,809 | RGD:6480464 | CTD | |
| G | DACT2 | dapper, antagonist of beta-catenin, homolog 2 (Xenopus laevis) |
|
affects expression | ISO | 6 | 168,707,584 | 168,720,402 | RGD:6480464 | CTD | |
| G | DACT2 | dapper, antagonist of beta-catenin, homolog 2 (Xenopus laevis) |
|
multiple interactions | EXP | 6 | 168,707,584 | 168,720,402 | RGD:6480464 | CTD | |
| G | DACT3 | dapper, antagonist of beta-catenin, homolog 3 (Xenopus laevis) |
|
increases expression | EXP | 19 | 47,150,869 | 47,164,395 | RGD:6480464 | CTD | |
| G | DAGLA | diacylglycerol lipase, alpha |
|
affects expression | ISO | 11 | 61,447,905 | 61,514,474 | RGD:6480464 | CTD | |
| G | DAK | dihydroxyacetone kinase 2 homolog (S. cerevisiae) |
|
affects expression | ISO | 11 | 61,100,654 | 61,116,231 | RGD:6480464 | CTD | |
| G | DALRD3 | DALR anticodon binding domain containing 3 |
|
increases expression | ISO | 3 | 49,052,435 | 49,058,467 | RGD:6480464 | CTD | |
| G | DANCR | differentiation antagonizing non-protein coding RNA |
|
multiple interactions | EXP | 4 | 53,578,621 | 53,580,305 | RGD:6480464 | CTD | |
| G | DAP | death-associated protein |
|
increases expression | ISO | 5 | 10,679,342 | 10,761,387 | RGD:6480464 | CTD | |
| G | DAP3 | death associated protein 3 |
|
increases expression | ISO | 1 | 155,658,882 | 155,708,801 | RGD:6480464 | CTD | |
| G | DAPK1 | death-associated protein kinase 1 |
|
affects expression | ISO | 9 | 90,112,756 | 90,323,549 | RGD:6480464 | CTD | |
| G | DAPK2 | death-associated protein kinase 2 |
|
increases expression | ISO | 15 | 64,199,235 | 64,338,521 | RGD:6480464 | CTD | |
| G | DAPK3 | death-associated protein kinase 3 |
|
affects expression | ISO | 19 | 3,958,452 | 3,969,826 | RGD:6480464 | CTD | |
| G | DAZAP1 | DAZ associated protein 1 |
|
affects expression | ISO | 19 | 1,407,584 | 1,435,683 | RGD:6480464 | CTD | |
| G | DAZAP1 | DAZ associated protein 1 |
|
decreases expression | ISO | 19 | 1,407,584 | 1,435,683 | RGD:6480464 | CTD | |
| G | DAZAP1 | DAZ associated protein 1 |
|
increases expression | ISO | 19 | 1,407,584 | 1,435,683 | RGD:6480464 | CTD | |
| G | DBF4B | DBF4 homolog B (S. cerevisiae) |
|
multiple interactions | EXP | 17 | 42,785,976 | 42,829,637 | RGD:6480464 | CTD | |
| G | DBI | diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
multiple interactions | EXP | 2 | 120,124,504 | 120,130,122 | RGD:6480464 | CTD | |
| G | DBI | diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
affects expression | ISO | 2 | 120,124,504 | 120,130,122 | RGD:6480464 | CTD | |
| G | DBP | D site of albumin promoter (albumin D-box) binding protein |
|
affects expression | ISO | 19 | 49,133,817 | 49,140,639 | RGD:6480464 | CTD | |
| G | DCAF12 | DDB1 and CUL4 associated factor 12 |
|
affects expression | ISO | 9 | 34,086,381 | 34,126,771 | RGD:6480464 | CTD | |
| G | DCAF12L1 | DDB1 and CUL4 associated factor 12-like 1 |
|
affects expression | ISO | X | 125,683,366 | 125,686,842 | RGD:6480464 | CTD | |
| G | DCAF13 | DDB1 and CUL4 associated factor 13 |
|
affects expression | ISO | 8 | 104,426,942 | 104,455,681 | RGD:6480464 | CTD | |
| G | DCAF15 | DDB1 and CUL4 associated factor 15 |
|
affects expression | ISO | 19 | 14,063,319 | 14,072,256 | RGD:6480464 | CTD | |
| G | DCAF5 | DDB1 and CUL4 associated factor 5 |
|
increases expression | EXP | 14 | 69,517,637 | 69,619,914 | RGD:6480464 | CTD | |
| G | DCAF6 | DDB1 and CUL4 associated factor 6 |
|
increases expression | EXP | 1 | 167,905,797 | 168,045,081 | RGD:6480464 | CTD | |
| G | DCAF7 | DDB1 and CUL4 associated factor 7 |
|
affects expression | ISO | 17 | 61,627,822 | 61,671,641 | RGD:6480464 | CTD | |
| G | DCAF8 | DDB1 and CUL4 associated factor 8 |
|
multiple interactions | EXP | 1 | 160,185,505 | 160,232,350 | RGD:6480464 | CTD | |
| G | DCBLD1 | discoidin, CUB and LCCL domain containing 1 |
|
affects expression | ISO | 6 | 117,803,820 | 117,891,021 | RGD:6480464 | CTD | |
| G | DCLK2 | doublecortin-like kinase 2 |
|
affects expression | ISO | 4 | 150,999,426 | 151,178,609 | RGD:6480464 | CTD | |
| G | DCLRE1C | DNA cross-link repair 1C |
|
multiple interactions | EXP | 10 | 14,948,870 | 14,996,094 | RGD:6480464 | CTD | |
| G | DENND6A | DENN/MADD domain containing 6A |
|
affects expression | ISO | 3 | 57,611,181 | 57,678,816 | RGD:6480464 | CTD | |
| G | DIS3L | DIS3 mitotic control homolog (S. cerevisiae)-like |
|
affects expression | ISO | 15 | 66,585,633 | 66,626,236 | RGD:6480464 | CTD | |
| G | DIXDC1 | DIX domain containing 1 |
|
affects expression | ISO | 11 | 111,807,927 | 111,893,308 | RGD:6480464 | CTD | |
| G | DKC1 | dyskeratosis congenita 1, dyskerin |
|
decreases expression | EXP | X | 153,991,031 | 154,005,964 | RGD:6480464 | CTD | |
| G | DKK3 | dickkopf 3 homolog (Xenopus laevis) |
|
affects expression | ISO | 11 | 11,984,543 | 12,030,917 | RGD:6480464 | CTD | |
| G | DKK3 | dickkopf 3 homolog (Xenopus laevis) |
|
increases expression | EXP | 11 | 11,984,543 | 12,030,917 | RGD:6480464 | CTD | |
| G | DKKL1 | dickkopf-like 1 |
|
increases expression | ISO | 19 | 49,866,987 | 49,878,373 | RGD:6480464 | CTD | |
| G | DLAT | dihydrolipoamide S-acetyltransferase |
|
multiple interactions | EXP | 11 | 111,895,538 | 111,935,002 | RGD:6480464 | CTD | |
| G | DLAT | dihydrolipoamide S-acetyltransferase |
|
affects expression | ISO | 11 | 111,895,538 | 111,935,002 | RGD:6480464 | CTD | |
| G | DLC1 | deleted in liver cancer 1 |
|
affects expression | ISO | 8 | 12,940,872 | 13,372,429 | RGD:6480464 | CTD | |
| G | DLC1 | deleted in liver cancer 1 |
|
decreases expression | ISO | 8 | 12,940,872 | 13,372,429 | RGD:6480464 | CTD | |
| G | DLEU7 | deleted in lymphocytic leukemia, 7 |
|
decreases expression | ISO | 13 | 51,286,759 | 51,417,885 | RGD:6480464 | CTD | |
| G | DLG2 | discs, large homolog 2 (Drosophila) |
|
affects expression | ISO | 11 | 83,166,055 | 85,338,314 | RGD:6480464 | CTD | |
| G | DLG5 | discs, large homolog 5 (Drosophila) |
|
increases expression | ISO | 10 | 79,550,549 | 79,686,348 | RGD:6480464 | CTD | |
| G | DLG5 | discs, large homolog 5 (Drosophila) |
|
decreases expression | ISO | 10 | 79,550,549 | 79,686,348 | RGD:6480464 | CTD | |
| G | DLK2 | delta-like 2 homolog (Drosophila) |
|
affects expression | ISO | 6 | 43,418,090 | 43,423,786 | RGD:6480464 | CTD | |
| G | DLL4 | delta-like 4 (Drosophila) |
|
affects expression | ISO | 15 | 41,221,531 | 41,231,258 | RGD:6480464 | CTD | |
| G | DLST | dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
|
affects expression | ISO | 14 | 75,348,594 | 75,370,450 | RGD:6480464 | CTD | |
| G | DLST | dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
|
multiple interactions | ISO | 14 | 75,348,594 | 75,370,450 | RGD:6480464 | CTD | |
| G | DLX2 | distal-less homeobox 2 |
|
increases expression | EXP | 2 | 172,964,166 | 172,967,478 | RGD:6480464 | CTD | |
| G | DMBX1 | diencephalon/mesencephalon homeobox 1 |
|
affects expression | ISO | 1 | 46,972,668 | 46,979,898 | RGD:6480464 | CTD | |
| G | DMRT1 | doublesex and mab-3 related transcription factor 1 |
|
affects expression | ISO | 9 | 841,690 | 969,090 | RGD:6480464 | CTD | |
| G | DMRT2 | doublesex and mab-3 related transcription factor 2 |
|
affects expression | ISO | 9 | 1,050,346 | 1,057,554 | RGD:6480464 | CTD | |
| G | DMRTA2 | DMRT-like family A2 |
|
decreases expression | ISO | 1 | 50,883,223 | 50,889,119 | RGD:6480464 | CTD | |
| G | DMRTA2 | DMRT-like family A2 |
|
increases expression | ISO | 1 | 50,883,223 | 50,889,119 | RGD:6480464 | CTD | |
| G | DMXL2 | Dmx-like 2 |
|
increases expression | ISO | 15 | 51,739,921 | 51,914,967 | RGD:6480464 | CTD | |
| G | DNAH14 | dynein, axonemal, heavy chain 14 |
|
multiple interactions | EXP | 1 | 225,117,356 | 225,586,996 | RGD:6480464 | CTD | |
| G | DNAI1 | dynein, axonemal, intermediate chain 1 |
|
affects expression | ISO | 9 | 34,458,811 | 34,520,982 | RGD:6480464 | CTD | |
| G | DNAJA1 | DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
affects expression | ISO | 9 | 33,025,209 | 33,039,062 | RGD:6480464 | CTD | |
| G | DNAJA3 | DnaJ (Hsp40) homolog, subfamily A, member 3 |
|
affects expression | ISO | 16 | 4,475,806 | 4,506,776 | RGD:6480464 | CTD | |
| G | DNAJA3 | DnaJ (Hsp40) homolog, subfamily A, member 3 |
|
multiple interactions | EXP | 16 | 4,475,806 | 4,506,776 | RGD:6480464 | CTD | |
| G | DNAJB11 | DnaJ (Hsp40) homolog, subfamily B, member 11 |
|
affects expression | ISO | 3 | 186,288,467 | 186,303,589 | RGD:6480464 | CTD | |
| G | DNAJB12 | DnaJ (Hsp40) homolog, subfamily B, member 12 |
|
affects expression | ISO | 10 | 74,092,588 | 74,114,907 | RGD:6480464 | CTD | |
| G | DNAJB12 | DnaJ (Hsp40) homolog, subfamily B, member 12 |
|
decreases expression | ISO | 10 | 74,092,588 | 74,114,907 | RGD:6480464 | CTD | |
| G | DNAJB3 | DnaJ (Hsp40) homolog, subfamily B, member 3 |
|
affects expression | ISO | 2 | 234,651,396 | 234,652,661 | RGD:6480464 | CTD | |
| G | DNAJB5 | DnaJ (Hsp40) homolog, subfamily B, member 5 |
|
increases expression | EXP | 9 | 34,989,638 | 34,998,430 | RGD:6480464 | CTD | |
| G | DNAJB9 | DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
affects expression | ISO | 7 | 108,210,189 | 108,215,294 | RGD:6480464 | CTD | |
| G | DNAJC1 | DnaJ (Hsp40) homolog, subfamily C, member 1 |
|
increases expression | EXP | 10 | 22,045,477 | 22,292,650 | RGD:6480464 | CTD | |
| G | DNAJC1 | DnaJ (Hsp40) homolog, subfamily C, member 1 |
|
affects expression | ISO | 10 | 22,045,477 | 22,292,650 | RGD:6480464 | CTD | |
| G | DNAJC10 | DnaJ (Hsp40) homolog, subfamily C, member 10 |
|
affects expression | ISO | 2 | 183,580,999 | 183,643,255 | RGD:6480464 | CTD | |
| G | DNAJC12 | DnaJ (Hsp40) homolog, subfamily C, member 12 |
|
increases expression | ISO | 10 | 69,556,427 | 69,597,937 | RGD:6480464 | CTD | |
| G | DNAJC18 | DnaJ (Hsp40) homolog, subfamily C, member 18 |
|
affects expression | ISO | 5 | 138,745,892 | 138,775,214 | RGD:6480464 | CTD | |
| G | DNAJC3 | DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
multiple interactions | EXP | 13 | 96,329,393 | 96,447,243 | RGD:6480464 | CTD | |
| G | DNAJC4 | DnaJ (Hsp40) homolog, subfamily C, member 4 |
|
affects expression | ISO | 11 | 63,997,753 | 64,001,753 | RGD:6480464 | CTD | |
| G | DNAJC5 | DnaJ (Hsp40) homolog, subfamily C, member 5 |
|
affects expression | ISO | 20 | 62,526,455 | 62,567,384 | RGD:6480464 | CTD | |
| G | DNAJC8 | DnaJ (Hsp40) homolog, subfamily C, member 8 |
|
multiple interactions | EXP | 1 | 28,526,789 | 28,559,542 | RGD:6480464 | CTD | |
| G | DNAJC8 | DnaJ (Hsp40) homolog, subfamily C, member 8 |
|
affects expression | ISO | 1 | 28,526,789 | 28,559,542 | RGD:6480464 | CTD | |
| G | DNASE1 | deoxyribonuclease I |
|
affects expression | ISO | 16 | 3,702,940 | 3,708,096 | RGD:6480464 | CTD | |
| G | DNHD1 | dynein heavy chain domain 1 |
|
multiple interactions | EXP | 11 | 6,518,526 | 6,593,255 | RGD:6480464 | CTD | |
| G | DNM1 | dynamin 1 |
|
increases expression | ISO | 9 | 130,965,663 | 131,017,527 | RGD:6480464 | CTD | |
| G | DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases expression | ISO | 20 | 31,350,191 | 31,397,162 | RGD:6480464 | CTD | |
| G | DNPEP | aspartyl aminopeptidase |
|
affects expression | ISO | 2 | 220,238,180 | 220,252,662 | RGD:6480464 | CTD | |
| G | DOCK9 | dedicator of cytokinesis 9 |
|
increases expression | ISO | 13 | 99,445,741 | 99,738,660 | RGD:6480464 | CTD | |
| G | DOHH | deoxyhypusine hydroxylase/monooxygenase |
|
affects expression | ISO | 19 | 3,490,819 | 3,500,938 | RGD:6480464 | CTD | |
| G | DOK2 | docking protein 2, 56kDa |
|
affects expression | ISO | 8 | 21,766,384 | 21,771,205 | RGD:6480464 | CTD | |
| G | DOK4 | docking protein 4 |
|
increases expression | ISO | 16 | 57,505,870 | 57,520,385 | RGD:6480464 | CTD | |
| G | DOPEY2 | dopey family member 2 |
|
affects expression | ISO | 21 | 37,536,839 | 37,666,572 | RGD:6480464 | CTD | |
| G | DPH1 | DPH1 homolog (S. cerevisiae) |
|
affects expression | ISO | 17 | 1,933,431 | 1,946,725 | RGD:6480464 | CTD | |
| G | DPH2 | DPH2 homolog (S. cerevisiae) |
|
decreases expression | ISO | 1 | 44,435,653 | 44,439,043 | RGD:6480464 | CTD | |
| G | DPH5 | DPH5 homolog (S. cerevisiae) |
|
decreases expression | ISO | 1 | 101,455,179 | 101,491,362 | RGD:6480464 | CTD | |
| G | DPM1 | dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit |
|
increases expression | ISO | 20 | 49,551,405 | 49,575,060 | RGD:6480464 | CTD | |
| G | DPP7 | dipeptidyl-peptidase 7 |
|
affects expression | ISO | 9 | 140,004,992 | 140,009,195 | RGD:6480464 | CTD | |
| G | DPY19L1 | dpy-19-like 1 (C. elegans) |
|
affects expression | ISO | 7 | 34,968,493 | 35,077,653 | RGD:6480464 | CTD | |
| G | EFS | embryonal Fyn-associated substrate |
|
decreases expression | EXP | 14 | 23,825,611 | 23,834,842 | RGD:6480464 | CTD | |
| G | EFS | embryonal Fyn-associated substrate |
|
decreases expression | ISO | 14 | 23,825,611 | 23,834,842 | RGD:6480464 | CTD | |
| G | EGF | epidermal growth factor |
|
multiple interactions | EXP | 4 | 110,834,040 | 110,934,118 | RGD:6480464 | CTD | |
| G | EGLN1 | egl nine homolog 1 (C. elegans) |
|
decreases expression | ISO | 1 | 231,499,497 | 231,560,790 | RGD:6480464 | CTD | |
| G | EGR1 | early growth response 1 |
|
affects expression | ISO | 5 | 137,801,181 | 137,805,004 | RGD:6480464 | CTD | |
| G | EGR2 | early growth response 2 |
|
decreases expression | ISO | 10 | 64,571,756 | 64,578,927 | RGD:6480464 | CTD | |
| G | EHBP1L1 | EH domain binding protein 1-like 1 |
|
affects expression | ISO | 11 | 65,343,509 | 65,360,116 | RGD:6480464 | CTD | |
| G | EHD1 | EH-domain containing 1 |
|
increases expression | EXP | 11 | 64,620,208 | 64,646,191 | RGD:6480464 | CTD | |
| G | EHD1 | EH-domain containing 1 |
|
affects expression | ISO | 11 | 64,620,208 | 64,646,191 | RGD:6480464 | CTD | |
| G | EHD2 | EH-domain containing 2 |
|
affects expression | ISO | 19 | 48,216,601 | 48,246,391 | RGD:6480464 | CTD | |
| G | EHD3 | EH-domain containing 3 |
|
affects expression | ISO | 2 | 31,456,880 | 31,491,260 | RGD:6480464 | CTD | |
| G | EHD4 | EH-domain containing 4 |
|
increases expression | EXP | 15 | 42,191,638 | 42,264,755 | RGD:6480464 | CTD | |
| G | EHHADH | enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
affects expression | ISO | 3 | 184,908,412 | 184,971,886 | RGD:6480464 | CTD | |
| G | EHMT2 | euchromatic histone-lysine N-methyltransferase 2 |
|
multiple interactions | EXP | 6 | 31,847,536 | 31,865,464 | RGD:6480464 | CTD | |
| G | EHMT2 | euchromatic histone-lysine N-methyltransferase 2 |
|
decreases expression | EXP | 6 | 31,847,536 | 31,865,464 | RGD:6480464 | CTD | |
| G | EHMT2 | euchromatic histone-lysine N-methyltransferase 2 |
|
affects expression | ISO | 6 | 31,847,536 | 31,865,464 | RGD:6480464 | CTD | |
| G | EI24 | etoposide induced 2.4 |
|
affects expression | ISO | 11 | 125,439,298 | 125,454,575 | RGD:6480464 | CTD | |
| G | EID3 | EP300 interacting inhibitor of differentiation 3 |
|
affects expression | ISO | 12 | 104,697,510 | 104,698,983 | RGD:6480464 | CTD | |
| G | EIF1AX | eukaryotic translation initiation factor 1A, X-linked |
|
affects expression | ISO | X | 20,142,636 | 20,159,966 | RGD:6480464 | CTD | |
| G | EIF1AY | eukaryotic translation initiation factor 1A, Y-linked |
|
multiple interactions | EXP | Y | 22,737,611 | 22,755,040 | RGD:6480464 | CTD | |
| G | EIF2AK1 | eukaryotic translation initiation factor 2-alpha kinase 1 |
|
affects expression | ISO | 7 | 6,061,878 | 6,098,860 | RGD:6480464 | CTD | |
| G | EIF2AK3 | eukaryotic translation initiation factor 2-alpha kinase 3 |
|
affects expression | ISO | 2 | 88,856,259 | 88,927,094 | RGD:6480464 | CTD | |
| G | EIF2AK3 | eukaryotic translation initiation factor 2-alpha kinase 3 |
|
increases expression | ISO | 2 | 88,856,259 | 88,927,094 | RGD:6480464 | CTD | |
| G | EIF2B1 | eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa |
|
affects expression | ISO | 12 | 124,105,570 | 124,118,323 | RGD:6480464 | CTD | |
| G | EIF2B3 | eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa |
|
affects expression | ISO | 1 | 45,316,194 | 45,452,394 | RGD:6480464 | CTD | |
| G | EIF2B4 | eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa |
|
affects expression | ISO | 2 | 27,587,219 | 27,593,324 | RGD:6480464 | CTD | |
| G | EIF2S1 | eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
|
affects expression | ISO | 14 | 67,827,034 | 67,853,233 | RGD:6480464 | CTD | |
| G | EIF3A | eukaryotic translation initiation factor 3, subunit A |
|
decreases expression | ISO | 10 | 120,794,541 | 120,840,334 | RGD:6480464 | CTD | |
| G | EIF3CL | eukaryotic translation initiation factor 3, subunit C-like |
|
decreases expression | EXP | 16 | 28,390,900 | 28,415,162 | RGD:6480464 | CTD | |
| G | EIF3D | eukaryotic translation initiation factor 3, subunit D |
|
decreases expression | ISO | 22 | 36,906,897 | 36,925,277 | RGD:6480464 | CTD | |
| G | EIF3D | eukaryotic translation initiation factor 3, subunit D |
|
affects expression | ISO | 22 | 36,906,897 | 36,925,277 | RGD:6480464 | CTD | |
| G | EIF3D | eukaryotic translation initiation factor 3, subunit D |
|
decreases expression | EXP | 22 | 36,906,897 | 36,925,277 | RGD:6480464 | CTD | |
| G | EIF3G | eukaryotic translation initiation factor 3, subunit G |
|
affects expression | ISO | 19 | 10,225,690 | 10,230,599 | RGD:6480464 | CTD | |
| G | EIF3J | eukaryotic translation initiation factor 3, subunit J |
|
affects expression | ISO | 15 | 44,829,266 | 44,855,001 | RGD:6480464 | CTD | |
| G | EIF4A1 | eukaryotic translation initiation factor 4A1 |
|
decreases expression | ISO | 17 | 7,476,024 | 7,482,324 | RGD:6480464 | CTD | |
| G | EIF4A3 | eukaryotic translation initiation factor 4A3 |
|
affects expression | ISO | 17 | 78,109,013 | 78,120,982 | RGD:6480464 | CTD | |
| G | EIF4B | eukaryotic translation initiation factor 4B |
|
multiple interactions | EXP | 12 | 53,400,062 | 53,435,993 | RGD:6480464 | CTD | |
| G | EIF4E2 | eukaryotic translation initiation factor 4E family member 2 |
|
affects expression | ISO | 2 | 233,415,357 | 233,433,920 | RGD:6480464 | CTD | |
| G | EIF4E3 | eukaryotic translation initiation factor 4E family member 3 |
|
affects expression | ISO | 3 | 71,728,440 | 71,803,924 | RGD:6480464 | CTD | |
| G | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 |
|
decreases expression | EXP | 8 | 37,888,020 | 37,917,883 | RGD:6480464 | CTD | |
| G | EIF4EBP3 | eukaryotic translation initiation factor 4E binding protein 3 |
|
increases expression | EXP | 5 | 139,927,251 | 139,929,163 | RGD:6480464 | CTD | |
| G | EIF4G3 | eukaryotic translation initiation factor 4 gamma, 3 |
|
multiple interactions | EXP | 1 | 21,132,785 | 21,503,381 | RGD:6480464 | CTD | |
| G | EIF5 | eukaryotic translation initiation factor 5 |
|
decreases expression | ISO | 14 | 103,800,339 | 103,811,362 | RGD:6480464 | CTD | |
| G | EIF6 | eukaryotic translation initiation factor 6 |
|
decreases expression | EXP | 20 | 33,866,709 | 33,872,619 | RGD:6480464 | CTD | |
| G | EIF6 | eukaryotic translation initiation factor 6 |
|
affects expression | ISO | 20 | 33,866,709 | 33,872,619 | RGD:6480464 | CTD | |
| G | ELAC2 | elaC homolog 2 (E. coli) |
|
affects expression | ISO | 17 | 12,894,929 | 12,921,381 | RGD:6480464 | CTD | |
| G | ELAVL1 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) |
|
decreases expression | EXP | 19 | 8,023,457 | 8,070,529 | RGD:6480464 | CTD | |
| G | ELAVL1 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) |
|
increases expression | EXP | 19 | 8,023,457 | 8,070,529 | RGD:6480464 | CTD | |
| G | ELAVL2 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) |
|
decreases expression | ISO | 9 | 23,690,102 | 23,826,063 | RGD:6480464 | CTD | |
| G | ELK1 | ELK1, member of ETS oncogene family |
|
multiple interactions | EXP | X | 47,494,919 | 47,510,003 | RGD:6480464 | CTD | |
| G | ELK1 | ELK1, member of ETS oncogene family |
|
increases activity | EXP | X | 47,494,919 | 47,510,003 | RGD:6480464 | CTD | |
| G | ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) |
|
affects expression | ISO | 12 | 96,588,207 | 96,661,606 | RGD:6480464 | CTD | |
| G | ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) |
|
multiple interactions | EXP | 12 | 96,588,207 | 96,661,606 | RGD:6480464 | CTD | |
| G | ELL | elongation factor RNA polymerase II |
|
multiple interactions | EXP | 19 | 18,553,473 | 18,632,937 | RGD:6480464 | CTD | |
| G | ELL2 | elongation factor, RNA polymerase II, 2 |
|
increases expression | EXP | 5 | 95,220,802 | 95,297,775 | RGD:6480464 | CTD | |
| G | ELL3 | elongation factor RNA polymerase II-like 3 |
|
multiple interactions | EXP | 15 | 44,064,798 | 44,069,502 | RGD:6480464 | CTD | |
| G | ELL3 | elongation factor RNA polymerase II-like 3 |
|
affects expression | ISO | 15 | 44,064,798 | 44,069,502 | RGD:6480464 | CTD | |
| G | ELMO3 | engulfment and cell motility 3 |
|
affects expression | ISO | 16 | 67,233,028 | 67,237,927 | RGD:6480464 | CTD | |
| G | ERMP1 | endoplasmic reticulum metallopeptidase 1 |
|
increases expression | EXP | 9 | 5,784,572 | 5,833,081 | RGD:6480464 | CTD | |
| G | ERRFI1 | ERBB receptor feedback inhibitor 1 |
|
affects expression | ISO | 1 | 8,071,779 | 8,086,393 | RGD:6480464 | CTD | |
| G | ESD | esterase D |
|
increases expression | EXP | 13 | 47,345,391 | 47,371,367 | RGD:6480464 | CTD | |
| G | ESR1 | estrogen receptor 1 |
|
increases expression | EXP | 6 | 152,011,631 | 152,424,409 | RGD:6480464 | CTD | |
| G | ESR2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | EXP | 14 | 64,693,751 | 64,805,268 | RGD:6480464 | CTD | |
| G | ESX1 | ESX homeobox 1 |
|
affects expression | ISO | X | 103,494,719 | 103,499,599 | RGD:6480464 | CTD | |
| G | ESYT1 | extended synaptotagmin-like protein 1 |
|
increases expression | ISO | 12 | 56,521,986 | 56,538,460 | RGD:6480464 | CTD | |
| G | ETAA1 | Ewing tumor-associated antigen 1 |
|
affects expression | ISO | 2 | 67,624,442 | 67,637,533 | RGD:6480464 | CTD | |
| G | ETF1 | eukaryotic translation termination factor 1 |
|
affects expression | ISO | 5 | 137,841,782 | 137,878,989 | RGD:6480464 | CTD | |
| G | ETFDH | electron-transferring-flavoprotein dehydrogenase |
|
affects expression | ISO | 4 | 159,593,277 | 159,629,842 | RGD:6480464 | CTD | |
| G | ETHE1 | ethylmalonic encephalopathy 1 |
|
affects expression | ISO | 19 | 44,010,871 | 44,031,396 | RGD:6480464 | CTD | |
| G | ETHE1 | ethylmalonic encephalopathy 1 |
|
increases expression | ISO | 19 | 44,010,871 | 44,031,396 | RGD:6480464 | CTD | |
| G | ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
|
increases expression | EXP | 11 | 128,328,656 | 128,457,453 | RGD:6480464 | CTD | |
| G | ETV5 | ets variant 5 |
|
decreases expression | ISO | 3 | 185,764,106 | 185,826,901 | RGD:6480464 | CTD | |
| G | ETV6 | ets variant 6 |
|
affects expression | ISO | 12 | 11,802,788 | 12,048,336 | RGD:6480464 | CTD | |
| G | EVC2 | Ellis van Creveld syndrome 2 |
|
decreases expression | ISO | 4 | 5,564,146 | 5,711,275 | RGD:6480464 | CTD | |
| G | EVC2 | Ellis van Creveld syndrome 2 |
|
increases expression | ISO | 4 | 5,564,146 | 5,711,275 | RGD:6480464 | CTD | |
| G | EVI2B | ecotropic viral integration site 2B |
|
affects expression | ISO | 17 | 29,630,788 | 29,641,130 | RGD:6480464 | CTD | |
| G | EVI5L | ecotropic viral integration site 5-like |
|
increases expression | ISO | 19 | 7,895,161 | 7,929,862 | RGD:6480464 | CTD | |
| G | EVI5L | ecotropic viral integration site 5-like |
|
increases expression | ISO | 19 | 7,895,161 | 7,929,862 | RGD:6480464 | CTD | |
| G | EWSR1 | Ewing sarcoma breakpoint region 1 |
|
affects expression | ISO | 22 | 29,663,998 | 29,696,515 | RGD:6480464 | CTD | |
| G | EXO1 | exonuclease 1 |
|
decreases expression | ISO | 1 | 242,011,493 | 242,053,241 | RGD:6480464 | CTD | |
| G | EXOC3L2 | exocyst complex component 3-like 2 |
|
multiple interactions | EXP | 19 | 45,715,879 | 45,737,469 | RGD:6480464 | CTD | |
| G | EXOC7 | exocyst complex component 7 |
|
multiple interactions | EXP | 17 | 74,077,086 | 74,099,868 | RGD:6480464 | CTD | |
| G | EXOC7 | exocyst complex component 7 |
|
affects expression | ISO | 17 | 74,077,086 | 74,099,868 | RGD:6480464 | CTD | |
| G | EXOSC1 | exosome component 1 |
|
affects expression | ISO | 10 | 99,195,666 | 99,205,768 | RGD:6480464 | CTD | |
| G | EXOSC4 | exosome component 4 |
|
affects expression | ISO | 8 | 145,133,522 | 145,135,551 | RGD:6480464 | CTD | |
| G | EXOSC9 | exosome component 9 |
|
affects expression | ISO | 4 | 122,722,472 | 122,738,176 | RGD:6480464 | CTD | |
| G | EXTL1 | exostosin-like glycosyltransferase 1 |
|
affects expression | ISO | 1 | 26,348,271 | 26,362,955 | RGD:6480464 | CTD | |
| G | EYA3 | eyes absent homolog 3 (Drosophila) |
|
affects expression | ISO | 1 | 28,296,855 | 28,415,148 | RGD:6480464 | CTD | |
| G | EZH2 | enhancer of zeste homolog 2 (Drosophila) |
|
affects expression | ISO | 7 | 148,504,464 | 148,581,441 | RGD:6480464 | CTD | |
| G | F10 | coagulation factor X |
|
decreases expression | ISO | 13 | 113,777,113 | 113,803,843 | RGD:6480464 | CTD | |
| G | F11R | F11 receptor |
|
multiple interactions | EXP | 1 | 160,965,001 | 160,991,133 | RGD:6480464 | CTD | |
| G | F12 | coagulation factor XII (Hageman factor) |
|
multiple interactions | EXP | 5 | 176,829,139 | 176,836,577 | RGD:6480464 | CTD | |
| G | F13A1 | coagulation factor XIII, A1 polypeptide |
|
decreases expression | EXP | 6 | 6,144,311 | 6,320,924 | RGD:6480464 | CTD | |
| G | F2R | coagulation factor II (thrombin) receptor |
|
decreases expression | ISO | 5 | 76,011,868 | 76,031,595 | RGD:6480464 | CTD | |
| G | F2RL1 | coagulation factor II (thrombin) receptor-like 1 |
|
increases expression | EXP | 5 | 76,114,833 | 76,131,140 | RGD:6480464 | CTD | |
| G | F2RL1 | coagulation factor II (thrombin) receptor-like 1 |
|
decreases expression | ISO | 5 | 76,114,833 | 76,131,140 | RGD:6480464 | CTD | |
| G | FABP1 | fatty acid binding protein 1, liver |
|
increases expression | ISO | 2 | 88,422,501 | 88,427,650 | RGD:6480464 | CTD | |
| G | FABP2 | fatty acid binding protein 2, intestinal |
|
affects response to substance | EXP | 4 | 120,238,405 | 120,243,316 | RGD:6480464 | CTD | |
| G | FABP6 | fatty acid binding protein 6, ileal |
|
affects expression | ISO | 5 | 159,614,374 | 159,665,729 | RGD:6480464 | CTD | |
| G | FABP9 | fatty acid binding protein 9, testis |
|
affects expression | ISO | 8 | 82,370,618 | 82,373,758 | RGD:6480464 | CTD | |
| G | FADS1 | fatty acid desaturase 1 |
|
affects expression | ISO | 11 | 61,567,097 | 61,584,529 | RGD:6480464 | CTD | |
| G | FADS2 | fatty acid desaturase 2 |
|
decreases expression | ISO | 11 | 61,595,713 | 61,634,825 | RGD:6480464 | CTD | |
| G | FADS3 | fatty acid desaturase 3 |
|
increases expression | EXP | 11 | 61,640,998 | 61,659,006 | RGD:6480464 | CTD | |
| G | FAF1 | Fas (TNFRSF6) associated factor 1 |
|
affects expression | ISO | 1 | 50,906,935 | 51,425,936 | RGD:6480464 | CTD | |
| G | FAF2 | Fas associated factor family member 2 |
|
affects expression | ISO | 5 | 175,875,356 | 175,937,075 | RGD:6480464 | CTD | |
| G | FAH | fumarylacetoacetate hydrolase (fumarylacetoacetase) |
|
increases expression | EXP | 15 | 80,445,233 | 80,478,924 | RGD:6480464 | CTD | |
| G | FAIM | Fas apoptotic inhibitory molecule |
|
decreases expression | EXP | 3 | 138,327,542 | 138,352,218 | RGD:6480464 | CTD | |
| G | FAIM | Fas apoptotic inhibitory molecule |
|
increases expression | ISO | 3 | 138,327,542 | 138,352,218 | RGD:6480464 | CTD | |
| G | FAM110C | family with sequence similarity 110, member C |
|
affects expression | ISO | 2 | 38,814 | 46,588 | RGD:6480464 | CTD | |
| G | FAM114A1 | family with sequence similarity 114, member A1 |
|
increases expression | EXP | 4 | 38,869,354 | 38,947,365 | RGD:6480464 | CTD | |
| G | FAM115C | family with sequence similarity 115, member C |
|
increases expression | ISO | 7 | 143,318,045 | 143,427,173 | RGD:6480464 | CTD | |
| G | FAM117A | family with sequence similarity 117, member A |
|
affects expression | ISO | 17 | 47,787,687 | 47,841,518 | RGD:6480464 | CTD | |
| G | FAM124B | family with sequence similarity 124B |
|
affects expression | ISO | 2 | 225,243,415 | 225,266,711 | RGD:6480464 | CTD | |
| G | FAM126A | family with sequence similarity 126, member A |
|
increases expression | EXP | 7 | 22,980,878 | 23,053,770 | RGD:6480464 | CTD | |
| G | FBXL20 | F-box and leucine-rich repeat protein 20 |
|
increases expression | ISO | 17 | 37,408,897 | 37,557,909 | RGD:6480464 | CTD | |
| G | FBXL8 | F-box and leucine-rich repeat protein 8 |
|
affects expression | ISO | 16 | 67,193,891 | 67,198,077 | RGD:6480464 | CTD | |
| G | FBXL8 | F-box and leucine-rich repeat protein 8 |
|
increases expression | ISO | 16 | 67,193,891 | 67,198,077 | RGD:6480464 | CTD | |
| G | FBXO2 | F-box protein 2 |
|
increases expression | EXP | 1 | 11,708,418 | 11,714,888 | RGD:6480464 | CTD | |
| G | FBXO2 | F-box protein 2 |
|
increases expression | ISO | 1 | 11,708,418 | 11,714,888 | RGD:6480464 | CTD | |
| G | FBXO21 | F-box protein 21 |
|
affects expression | ISO | 12 | 117,581,585 | 117,628,300 | RGD:6480464 | CTD | |
| G | FBXO25 | F-box protein 25 |
|
increases expression | EXP | 8 | 356,808 | 419,876 | RGD:6480464 | CTD | |
| G | FBXO28 | F-box protein 28 |
|
decreases expression | ISO | 1 | 224,301,789 | 224,349,749 | RGD:6480464 | CTD | |
| G | FBXO31 | F-box protein 31 |
|
affects expression | ISO | 16 | 87,362,942 | 87,425,708 | RGD:6480464 | CTD | |
| G | FBXO39 | F-box protein 39 |
|
affects expression | ISO | 17 | 6,679,552 | 6,690,965 | RGD:6480464 | CTD | |
| G | FBXO43 | F-box protein 43 |
|
affects expression | ISO | 8 | 101,145,588 | 101,158,099 | RGD:6480464 | CTD | |
| G | FBXO5 | F-box protein 5 |
|
decreases expression | ISO | 6 | 153,291,658 | 153,304,740 | RGD:6480464 | CTD | |
| G | FBXO6 | F-box protein 6 |
|
affects expression | ISO | 1 | 11,724,150 | 11,734,411 | RGD:6480464 | CTD | |
| G | FBXO7 | F-box protein 7 |
|
affects expression | ISO | 22 | 32,870,707 | 32,894,818 | RGD:6480464 | CTD | |
| G | FBXO9 | F-box protein 9 |
|
increases expression | EXP | 6 | 52,929,796 | 52,965,671 | RGD:6480464 | CTD | |
| G | FBXO9 | F-box protein 9 |
|
affects expression | ISO | 6 | 52,929,796 | 52,965,671 | RGD:6480464 | CTD | |
| G | FBXW4 | F-box and WD repeat domain containing 4 |
|
multiple interactions | EXP | 10 | 103,370,421 | 103,454,743 | RGD:6480464 | CTD | |
| G | FBXW9 | F-box and WD repeat domain containing 9 |
|
affects expression | ISO | 19 | 12,799,730 | 12,807,455 | RGD:6480464 | CTD | |
| G | FCER1A | Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
affects expression | ISO | 1 | 159,253,678 | 159,278,014 | RGD:6480464 | CTD | |
| G | FCF1 | FCF1 small subunit (SSU) processome component homolog (S. cerevisiae) |
|
affects expression | ISO | 14 | 75,179,850 | 75,203,394 | RGD:6480464 | CTD | |
| G | FCHO1 | FCH domain only 1 |
|
affects expression | ISO | 19 | 17,858,527 | 17,899,377 | RGD:6480464 | CTD | |
| G | FCHSD1 | FCH and double SH3 domains 1 |
|
affects expression | ISO | 5 | 141,018,869 | 141,030,986 | RGD:6480464 | CTD | |
| G | FCRL5 | Fc receptor-like 5 |
|
affects expression | ISO | 1 | 157,483,167 | 157,522,310 | RGD:6480464 | CTD | |
| G | FCRLA | Fc receptor-like A |
|
affects expression | ISO | 1 | 161,676,762 | 161,684,142 | RGD:6480464 | CTD | |
| G | FDFT1 | farnesyl-diphosphate farnesyltransferase 1 |
|
increases expression | EXP | 8 | 11,660,190 | 11,696,818 | RGD:6480464 | CTD | |
| G | FDFT1 | farnesyl-diphosphate farnesyltransferase 1 |
|
affects expression | ISO | 8 | 11,660,190 | 11,696,818 | RGD:6480464 | CTD | |
| G | FDPS | farnesyl diphosphate synthase |
|
affects expression | ISO | 1 | 155,278,539 | 155,290,457 | RGD:6480464 | CTD | |
| G | FDPS | farnesyl diphosphate synthase |
|
multiple interactions | EXP | 1 | 155,278,539 | 155,290,457 | RGD:6480464 | CTD | |
| G | FERMT2 | fermitin family member 2 |
|
affects expression | ISO | 14 | 53,323,989 | 53,417,815 | RGD:6480464 | CTD | |
| G | FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) |
|
increases expression | EXP | 11 | 125,315,641 | 125,366,206 | RGD:6480464 | CTD | |
| G | FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) |
|
increases expression | ISO | 11 | 125,315,641 | 125,366,206 | RGD:6480464 | CTD | |
| G | FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) |
|
affects expression | ISO | 11 | 125,315,641 | 125,366,206 | RGD:6480464 | CTD | |
| G | FFAR2 | free fatty acid receptor 2 |
|
affects expression | ISO | 19 | 35,940,617 | 35,942,669 | RGD:6480464 | CTD | |
| G | FFAR3 | free fatty acid receptor 3 |
|
multiple interactions | EXP | 19 | 35,849,488 | 35,851,391 | RGD:6480464 | CTD | |
| G | FGF1 | fibroblast growth factor 1 (acidic) |
|
affects expression | ISO | 5 | 141,971,743 | 142,077,635 | RGD:6480464 | CTD | |
| G | FGF12 | fibroblast growth factor 12 |
|
affects expression | ISO | 3 | 191,857,182 | 192,445,388 | RGD:6480464 | CTD | |
| G | FGF19 | fibroblast growth factor 19 |
|
decreases expression | ISO | 11 | 69,513,006 | 69,519,106 | RGD:6480464 | CTD | |
| G | FGF21 | fibroblast growth factor 21 |
|
affects expression | ISO | 19 | 49,259,344 | 49,261,582 | RGD:6480464 | CTD | |
| G | FGF21 | fibroblast growth factor 21 |
|
decreases expression | ISO | 19 | 49,259,344 | 49,261,582 | RGD:6480464 | CTD | |
| G | FGF23 | fibroblast growth factor 23 |
|
affects expression | ISO | 12 | 4,477,393 | 4,488,894 | RGD:6480464 | CTD | |
| G | FGF3 | fibroblast growth factor 3 |
|
affects expression | ISO | 11 | 69,624,736 | 69,634,192 | RGD:6480464 | CTD | |
| G | FGF4 | fibroblast growth factor 4 |
|
affects expression | ISO | 11 | 69,587,797 | 69,590,171 | RGD:6480464 | CTD | |
| G | FGF4 | fibroblast growth factor 4 |
|
decreases expression | ISO | 11 | 69,587,797 | 69,590,171 | RGD:6480464 | CTD | |
| G | FGF8 | fibroblast growth factor 8 (androgen-induced) |
|
multiple interactions | ISO | 10 | 103,529,887 | 103,540,126 | RGD:6480464 | CTD | |
| G | FGFBP3 | fibroblast growth factor binding protein 3 |
|
affects expression | ISO | 10 | 93,666,345 | 93,669,258 | RGD:6480464 | CTD | |
| G | FGFR1OP | FGFR1 oncogene partner |
|
decreases expression | ISO | 6 | 167,412,816 | 167,454,066 | RGD:6480464 | CTD | |
| G | FGFR3 | fibroblast growth factor receptor 3 |
|
increases expression | EXP | 4 | 1,795,039 | 1,810,599 | RGD:6480464 | CTD | |
| G | FGL1 | fibrinogen-like 1 |
|
affects expression | ISO | 8 | 17,721,900 | 17,753,047 | RGD:6480464 | CTD | |
| G | FH | fumarate hydratase |
|
affects expression | ISO | 1 | 241,660,857 | 241,683,085 | RGD:6480464 | CTD | |
| G | FHDC1 | FH2 domain containing 1 |
|
affects expression | ISO | 4 | 153,864,135 | 153,900,848 | RGD:6480464 | CTD | |
| G | FHL3 | four and a half LIM domains 3 |
|
affects expression | ISO | 1 | 38,462,442 | 38,471,187 | RGD:6480464 | CTD | |
| G | FHL5 | four and a half LIM domains 5 |
|
affects expression | ISO | 6 | 97,010,424 | 97,064,512 | RGD:6480464 | CTD | |
| G | FIBP | fibroblast growth factor (acidic) intracellular binding protein |
|
affects expression | ISO | 11 | 65,651,211 | 65,656,010 | RGD:6480464 | CTD | |
| G | FIG4 | FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae) |
|
increases expression | ISO | 6 | 110,012,424 | 110,146,634 | RGD:6480464 | CTD | |
| G | FIG4 | FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae) |
|
affects expression | ISO | 6 | 110,012,424 | 110,146,634 | RGD:6480464 | CTD | |
| G | FIS1 | fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) |
|
multiple interactions | EXP | 7 | 100,882,893 | 100,888,371 | RGD:6480464 | CTD | |
| G | FITM1 | fat storage-inducing transmembrane protein 1 |
|
affects expression | ISO | 14 | 24,600,675 | 24,602,058 | RGD:6480464 | CTD | |
| G | FIZ1 | FLT3-interacting zinc finger 1 |
|
decreases expression | EXP | 19 | 56,102,737 | 56,110,893 | RGD:6480464 | CTD | |
| G | FIZ1 | FLT3-interacting zinc finger 1 |
|
affects expression | ISO | 19 | 56,102,737 | 56,110,893 | RGD:6480464 | CTD | |
| G | FKBP11 | FK506 binding protein 11, 19 kDa |
|
affects expression | ISO | 12 | 49,315,742 | 49,319,330 | RGD:6480464 | CTD | |
| G | FKBP1B | FK506 binding protein 1B, 12.6 kDa |
|
affects expression | ISO | 2 | 24,272,584 | 24,286,551 | RGD:6480464 | CTD | |
| G | FKBP1B | FK506 binding protein 1B, 12.6 kDa |
|
increases expression | EXP | 2 | 24,272,584 | 24,286,551 | RGD:6480464 | CTD | |
| G | FKBP5 | FK506 binding protein 5 |
|
decreases expression | ISO | 6 | 35,541,362 | 35,696,360 | RGD:6480464 | CTD | |
| G | FLVCR1 | feline leukemia virus subgroup C cellular receptor 1 |
|
affects expression | ISO | 1 | 213,031,597 | 213,072,705 | RGD:6480464 | CTD | |
| G | GABBR1 | gamma-aminobutyric acid (GABA) B receptor, 1 |
|
affects expression | ISO | 6 | 29,570,005 | 29,600,962 | RGD:6480464 | CTD | |
| G | GABPA | GA binding protein transcription factor, alpha subunit 60kDa |
|
multiple interactions | ISO | 21 | 27,107,258 | 27,144,771 | RGD:6480464 | CTD | |
| G | GABPB1 | GA binding protein transcription factor, beta subunit 1 |
|
affects expression | ISO | 15 | 50,569,389 | 50,647,605 | RGD:6480464 | CTD | |
| G | GABPB1 | GA binding protein transcription factor, beta subunit 1 |
|
decreases expression | ISO | 15 | 50,569,389 | 50,647,605 | RGD:6480464 | CTD | |
| G | GABRA3 | gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
|
affects expression | ISO | X | 151,335,634 | 151,619,831 | RGD:6480464 | CTD | |
| G | GABRA5 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
|
affects expression | ISO | 15 | 27,111,866 | 27,194,357 | RGD:6480464 | CTD | |
| G | GABRA6 | gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
|
affects expression | ISO | 5 | 161,112,658 | 161,129,598 | RGD:6480464 | CTD | |
| G | GABRD | gamma-aminobutyric acid (GABA) A receptor, delta |
|
decreases expression | ISO | 1 | 1,950,768 | 1,962,192 | RGD:6480464 | CTD | |
| G | GAD1 | glutamate decarboxylase 1 (brain, 67kDa) |
|
multiple interactions | ISO | 2 | 171,673,200 | 171,717,661 | RGD:6480464 | CTD | |
| G | GAD1 | glutamate decarboxylase 1 (brain, 67kDa) |
|
multiple interactions | ISO | 2 | 171,673,200 | 171,717,661 | RGD:6480464 | CTD | |
| G | GAD1 | glutamate decarboxylase 1 (brain, 67kDa) |
|
multiple interactions | ISO | 2 | 171,673,200 | 171,717,661 | RGD:6480464 | CTD | |
| G | GAD1 | glutamate decarboxylase 1 (brain, 67kDa) |
|
multiple interactions | ISO | 2 | 171,673,200 | 171,717,661 | RGD:6480464 | CTD | |
| G | GAD1 | glutamate decarboxylase 1 (brain, 67kDa) |
|
decreases methylation | ISO | 2 | 171,673,200 | 171,717,661 | RGD:6480464 | CTD | |
| G | GAD1 | glutamate decarboxylase 1 (brain, 67kDa) |
|
increases expression | ISO | 2 | 171,673,200 | 171,717,661 | RGD:6480464 | CTD | |
| G | GAD1 | glutamate decarboxylase 1 (brain, 67kDa) |
|
increases expression | ISO | 2 | 171,673,200 | 171,717,661 | RGD:6480464 | CTD | |
| G | GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
|
affects expression | ISO | 10 | 26,505,236 | 26,593,491 | RGD:6480464 | CTD | |
| G | GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
|
increases expression | ISO | 10 | 26,505,236 | 26,593,491 | RGD:6480464 | CTD | |
| G | GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
|
decreases expression | ISO | 10 | 26,505,236 | 26,593,491 | RGD:6480464 | CTD | |
| G | GADD45A | growth arrest and DNA-damage-inducible, alpha |
|
increases expression | EXP | 1 | 68,150,860 | 68,154,021 | RGD:6480464 | CTD | |
| G | GADD45A | growth arrest and DNA-damage-inducible, alpha |
|
decreases expression | ISO | 1 | 68,150,860 | 68,154,021 | RGD:6480464 | CTD | |
| G | GADD45B | growth arrest and DNA-damage-inducible, beta |
|
affects expression | ISO | 19 | 2,476,123 | 2,478,257 | RGD:6480464 | CTD | |
| G | GADD45B | growth arrest and DNA-damage-inducible, beta |
|
increases expression | ISO | 19 | 2,476,123 | 2,478,257 | RGD:6480464 | CTD | |
| G | GADD45G | growth arrest and DNA-damage-inducible, gamma |
|
decreases expression | ISO | 9 | 92,219,927 | 92,221,470 | RGD:6480464 | CTD | |
| G | GADD45GIP1 | growth arrest and DNA-damage-inducible, gamma interacting protein 1 |
|
decreases expression | ISO | 19 | 13,064,970 | 13,068,068 | RGD:6480464 | CTD | |
| G | GAK | cyclin G associated kinase |
|
affects expression | ISO | 4 | 843,065 | 926,174 | RGD:6480464 | CTD | |
| G | GAL3ST1 | galactose-3-O-sulfotransferase 1 |
|
increases expression | ISO | 22 | 30,950,624 | 30,960,876 | RGD:6480464 | CTD | |
| G | GAL3ST4 | galactose-3-O-sulfotransferase 4 |
|
affects expression | ISO | 7 | 99,756,865 | 99,766,373 | RGD:6480464 | CTD | |
| G | GALE | UDP-galactose-4-epimerase |
|
affects expression | ISO | 1 | 24,122,089 | 24,127,294 | RGD:6480464 | CTD | |
| G | GALE | UDP-galactose-4-epimerase |
|
increases expression | EXP | 1 | 24,122,089 | 24,127,294 | RGD:6480464 | CTD | |
| G | GALM | galactose mutarotase (aldose 1-epimerase) |
|
affects expression | ISO | 2 | 38,893,052 | 38,961,909 | RGD:6480464 | CTD | |
| G | GALNS | galactosamine (N-acetyl)-6-sulfate sulfatase |
|
affects expression | ISO | 16 | 88,880,142 | 88,923,374 | RGD:6480464 | CTD | |
| G | GALNT1 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1) |
|
affects expression | ISO | 18 | 33,234,533 | 33,291,798 | RGD:6480464 | CTD | |
| G | GALNT12 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (GalNAc-T12) |
|
increases expression | ISO | 9 | 101,569,981 | 101,612,363 | RGD:6480464 | CTD | |
| G | GALNT16 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
|
increases expression | EXP | 14 | 69,726,681 | 69,821,190 | RGD:6480464 | CTD | |
| G | GALNT7 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) |
|
multiple interactions | EXP | 4 | 174,089,904 | 174,245,118 | RGD:6480464 | CTD | |
| G | GALP | galanin-like peptide |
|
multiple interactions | EXP | 19 | 56,687,389 | 56,697,144 | RGD:6480464 | CTD | |
| G | GALR2 | galanin receptor 2 |
|
decreases expression | ISO | 17 | 74,070,892 | 74,073,573 | RGD:6480464 | CTD | |
| G | GALR2 | galanin receptor 2 |
|
increases expression | ISO | 17 | 74,070,892 | 74,073,573 | RGD:6480464 | CTD | |
| G | GAMT | guanidinoacetate N-methyltransferase |
|
affects expression | ISO | 19 | 1,397,025 | 1,401,569 | RGD:6480464 | CTD | |
| G | GAMT | guanidinoacetate N-methyltransferase |
|
multiple interactions | EXP | 19 | 1,397,025 | 1,401,569 | RGD:6480464 | CTD | |
| G | GAMT | guanidinoacetate N-methyltransferase |
|
increases expression | ISO | 19 | 1,397,025 | 1,401,569 | RGD:6480464 | CTD | |
| G | GANAB | glucosidase, alpha; neutral AB |
|
multiple interactions | EXP | 11 | 62,392,298 | 62,414,104 | RGD:6480464 | CTD | |
| G | GAP43 | growth associated protein 43 |
|
increases expression | EXP | 3 | 115,342,151 | 115,440,334 | RGD:6480464 | CTD | |
| G | GAR1 | GAR1 ribonucleoprotein homolog (yeast) |
|
decreases expression | ISO | 4 | 110,736,666 | 110,745,893 | RGD:6480464 | CTD | |
| G | GARS | glycyl-tRNA synthetase |
|
affects expression | ISO | 7 | 30,634,181 | 30,673,649 | RGD:6480464 | CTD | |
| G | GAS1 | growth arrest-specific 1 |
|
affects expression | ISO | 9 | 89,559,277 | 89,562,104 | RGD:6480464 | CTD | |
| G | GAS2 | growth arrest-specific 2 |
|
increases expression | EXP | 11 | 22,688,160 | 22,834,547 | RGD:6480464 | CTD | |
| G | GAS2 | growth arrest-specific 2 |
|
decreases expression | ISO | 11 | 22,688,160 | 22,834,547 | RGD:6480464 | CTD | |
| G | GAS2L1 | growth arrest-specific 2 like 1 |
|
increases expression | ISO | 22 | 29,702,997 | 29,708,774 | RGD:6480464 | CTD | |
| G | GAS5 | growth arrest-specific 5 (non-protein coding) |
|
affects expression | ISO | 1 | 173,833,039 | 173,837,125 | RGD:6480464 | CTD | |
| G | GAS5 | growth arrest-specific 5 (non-protein coding) |
|
decreases expression | ISO | 1 | 173,833,039 | 173,837,125 | RGD:6480464 | CTD | |
| G | GATA3 | GATA binding protein 3 |
|
affects expression | ISO | 10 | 8,096,667 | 8,117,164 | RGD:6480464 | CTD | |
| G | GATA3 | GATA binding protein 3 |
|
increases expression | ISO | 10 | 8,096,667 | 8,117,164 | RGD:6480464 | CTD | |
| G | GATAD1 | GATA zinc finger domain containing 1 |
|
affects expression | ISO | 7 | 92,076,762 | 92,089,381 | RGD:6480464 | CTD | |
| G | GATAD2A | GATA zinc finger domain containing 2A |
|
affects expression | ISO | 19 | 19,496,642 | 19,619,741 | RGD:6480464 | CTD | |
| G | GATM | glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
|
increases expression | EXP | 15 | 45,653,322 | 45,670,980 | RGD:6480464 | CTD | |
| G | GATM | glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
|
affects expression | ISO | 15 | 45,653,322 | 45,670,980 | RGD:6480464 | CTD | |
| G | GBA2 | glucosidase, beta (bile acid) 2 |
|
affects expression | ISO | 9 | 35,736,863 | 35,749,225 | RGD:6480464 | CTD | |
| G | GBP1 | guanylate binding protein 1, interferon-inducible |
|
affects expression | ISO | 1 | 89,517,987 | 89,531,043 | RGD:6480464 | CTD | |
| G | GCC2 | GRIP and coiled-coil domain containing 2 |
|
affects expression | ISO | 2 | 109,065,577 | 109,125,854 | RGD:6480464 | CTD | |
| G | GCH1 | GTP cyclohydrolase 1 |
|
increases expression | ISO | 14 | 55,308,723 | 55,369,542 | RGD:6480464 | CTD | |
| G | GCOM1 | GRINL1A complex locus 1 |
|
multiple interactions | EXP | 15 | 57,884,102 | 58,009,755 | RGD:6480464 | CTD | |
| G | GJC1 | gap junction protein, gamma 1, 45kDa |
|
affects expression | ISO | 17 | 42,875,816 | 42,908,179 | RGD:6480464 | CTD | |
| G | GNAT2 | guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 |
|
affects expression | ISO | 1 | 110,145,889 | 110,155,705 | RGD:6480464 | CTD | |
| G | GOT2 | glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
multiple interactions | ISO | 16 | 58,741,035 | 58,768,246 | RGD:6480464 | CTD | |
| G | GP2 | glycoprotein 2 (zymogen granule membrane) |
|
multiple interactions | EXP | 16 | 20,321,811 | 20,338,835 | RGD:6480464 | CTD | |
| G | GPA33 | glycoprotein A33 (transmembrane) |
|
affects expression | ISO | 1 | 167,022,082 | 167,059,868 | RGD:6480464 | CTD | |
| G | GPAA1 | glycosylphosphatidylinositol anchor attachment 1 |
|
multiple interactions | EXP | 8 | 145,137,524 | 145,141,119 | RGD:6480464 | CTD | |
| G | GPAM | glycerol-3-phosphate acyltransferase, mitochondrial |
|
increases expression | ISO | 10 | 113,909,622 | 113,943,537 | RGD:6480464 | CTD | |
| G | GPAM | glycerol-3-phosphate acyltransferase, mitochondrial |
|
affects expression | ISO | 10 | 113,909,622 | 113,943,537 | RGD:6480464 | CTD | |
| G | GPANK1 | G patch domain and ankyrin repeats 1 |
|
affects expression | ISO | 6 | 31,629,006 | 31,634,060 | RGD:6480464 | CTD | |
| G | GPATCH2 | G patch domain containing 2 |
|
affects expression | ISO | 1 | 217,603,834 | 217,804,409 | RGD:6480464 | CTD | |
| G | GPATCH3 | G patch domain containing 3 |
|
affects expression | ISO | 1 | 27,216,979 | 27,226,962 | RGD:6480464 | CTD | |
| G | GPATCH4 | G patch domain containing 4 |
|
decreases expression | EXP | 1 | 156,564,100 | 156,571,279 | RGD:6480464 | CTD | |
| G | GPBP1L1 | GC-rich promoter binding protein 1-like 1 |
|
multiple interactions | EXP | 1 | 46,092,976 | 46,152,302 | RGD:6480464 | CTD | |
| G | GPC1 | glypican 1 |
|
affects expression | ISO | 2 | 241,375,115 | 241,407,495 | RGD:6480464 | CTD | |
| G | GPC4 | glypican 4 |
|
increases expression | EXP | X | 132,435,064 | 132,549,205 | RGD:6480464 | CTD | |
| G | GPM6A | glycoprotein M6A |
|
increases expression | EXP | 4 | 176,554,088 | 176,923,842 | RGD:6480464 | CTD | |
| G | GPN2 | GPN-loop GTPase 2 |
|
affects expression | ISO | 1 | 27,205,873 | 27,216,869 | RGD:6480464 | CTD | |
| G | GPR110 | G protein-coupled receptor 110 |
|
affects expression | ISO | 6 | 46,967,813 | 47,010,082 | RGD:6480464 | CTD | |
| G | GPR119 | G protein-coupled receptor 119 |
|
affects expression | ISO | X | 129,518,319 | 129,519,511 | RGD:6480464 | CTD | |
| G | GPR12 | G protein-coupled receptor 12 |
|
affects expression | ISO | 13 | 27,329,337 | 27,334,922 | RGD:6480464 | CTD | |
| G | GPR125 | G protein-coupled receptor 125 |
|
multiple interactions | EXP | 4 | 22,388,997 | 22,517,677 | RGD:6480464 | CTD | |
| G | GPR137B | G protein-coupled receptor 137B |
|
affects expression | ISO | 1 | 236,305,832 | 236,372,209 | RGD:6480464 | CTD | |
| G | GPR153 | G protein-coupled receptor 153 |
|
increases expression | ISO | 1 | 6,307,406 | 6,321,035 | RGD:6480464 | CTD | |
| G | GPR157 | G protein-coupled receptor 157 |
|
affects expression | ISO | 1 | 9,164,476 | 9,189,229 | RGD:6480464 | CTD | |
| G | GPR160 | G protein-coupled receptor 160 |
|
increases expression | ISO | 3 | 169,755,735 | 169,803,184 | RGD:6480464 | CTD | |
| G | GPR161 | G protein-coupled receptor 161 |
|
increases expression | ISO | 1 | 168,048,780 | 168,106,905 | RGD:6480464 | CTD | |
| G | GPR180 | G protein-coupled receptor 180 |
|
affects expression | ISO | 13 | 95,254,104 | 95,286,899 | RGD:6480464 | CTD | |
| G | GPR183 | G protein-coupled receptor 183 |
|
affects expression | ISO | 13 | 99,946,789 | 99,959,749 | RGD:6480464 | CTD | |
| G | GPR19 | G protein-coupled receptor 19 |
|
decreases expression | ISO | 12 | 12,813,995 | 12,849,121 | RGD:6480464 | CTD | |
| G | GPR33 | G protein-coupled receptor 33 (gene/pseudogene) |
|
affects expression | ISO | 14 | 31,952,150 | 31,957,151 | RGD:6480464 | CTD | |
| G | GPR37 | G protein-coupled receptor 37 (endothelin receptor type B-like) |
|
increases expression | EXP | 7 | 124,385,655 | 124,406,079 | RGD:6480464 | CTD | |
| G | GPR62 | G protein-coupled receptor 62 |
|
affects expression | ISO | 3 | 51,989,330 | 51,991,520 | RGD:6480464 | CTD | |
| G | GPR83 | G protein-coupled receptor 83 |
|
multiple interactions | EXP | 11 | 94,110,477 | 94,134,585 | RGD:6480464 | CTD | |
| G | GPR87 | G protein-coupled receptor 87 |
|
affects expression | ISO | 3 | 151,011,874 | 151,034,636 | RGD:6480464 | CTD | |
| G | GPR89B | G protein-coupled receptor 89B |
|
affects expression | ISO | 1 | 147,400,506 | 147,465,753 | RGD:6480464 | CTD | |
| G | GPR98 | G protein-coupled receptor 98 |
|
affects expression | ISO | 5 | 89,854,617 | 90,460,033 | RGD:6480464 | CTD | |
| G | GPRASP1 | G protein-coupled receptor associated sorting protein 1 |
|
affects expression | ISO | X | 101,906,294 | 101,914,011 | RGD:6480464 | CTD | |
| G | GPRASP1 | G protein-coupled receptor associated sorting protein 1 |
|
increases expression | EXP | X | 101,906,294 | 101,914,011 | RGD:6480464 | CTD | |
| G | GPRASP1 | G protein-coupled receptor associated sorting protein 1 |
|
increases expression | ISO | X | 101,906,294 | 101,914,011 | RGD:6480464 | CTD | |
| G | GPRIN1 | G protein regulated inducer of neurite outgrowth 1 |
|
increases expression | ISO | 5 | 176,022,803 | 176,037,131 | RGD:6480464 | CTD | |
| G | GPRIN3 | GPRIN family member 3 |
|
affects expression | ISO | 4 | 90,165,429 | 90,229,161 | RGD:6480464 | CTD | |
| G | GPS2 | G protein pathway suppressor 2 |
|
multiple interactions | EXP | 17 | 7,215,978 | 7,218,658 | RGD:6480464 | CTD | |
| G | GPT | glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions | ISO | 8 | 145,729,465 | 145,732,555 | RGD:6480464 | CTD | |
| G | GPT2 | glutamic pyruvate transaminase (alanine aminotransferase) 2 |
|
affects expression | ISO | 16 | 46,918,308 | 46,965,201 | RGD:6480464 | CTD | |
| G | GPX3 | glutathione peroxidase 3 (plasma) |
|
increases expression | EXP | 5 | 150,399,999 | 150,408,554 | RGD:6480464 | CTD | |
| G | GPX4 | glutathione peroxidase 4 |
|
affects expression | ISO | 19 | 1,103,936 | 1,106,787 | RGD:6480464 | CTD | |
| G | GPX7 | glutathione peroxidase 7 |
|
affects expression | ISO | 1 | 53,068,043 | 53,074,723 | RGD:6480464 | CTD | |
| G | GRAMD3 | GRAM domain containing 3 |
|
affects expression | ISO | 5 | 125,695,788 | 125,829,853 | RGD:6480464 | CTD | |
| G | GRAMD4 | GRAM domain containing 4 |
|
affects expression | ISO | 22 | 47,022,658 | 47,075,688 | RGD:6480464 | CTD | |
| G | GRAP | GRB2-related adaptor protein |
|
multiple interactions | EXP | 17 | 18,923,990 | 18,950,336 | RGD:6480464 | CTD | |
| G | GRB14 | growth factor receptor-bound protein 14 |
|
affects expression | ISO | 2 | 165,349,323 | 165,478,360 | RGD:6480464 | CTD | |
| G | GRB14 | growth factor receptor-bound protein 14 |
|
increases expression | ISO | 2 | 165,349,323 | 165,478,360 | RGD:6480464 | CTD | |
| G | GRB7 | growth factor receptor-bound protein 7 |
|
affects expression | ISO | 17 | 37,894,162 | 37,903,538 | RGD:6480464 | CTD | |
| G | GREB1 | growth regulation by estrogen in breast cancer 1 |
|
affects expression | ISO | 2 | 11,674,242 | 11,782,912 | RGD:6480464 | CTD | |
| G | GREM1 | gremlin 1, DAN family BMP antagonist |
|
affects expression | ISO | 15 | 33,010,205 | 33,026,870 | RGD:6480464 | CTD | |
| G | GRHL1 | grainyhead-like 1 (Drosophila) |
|
increases expression | EXP | 2 | 10,091,792 | 10,142,412 | RGD:6480464 | CTD | |
| G | GRHL1 | grainyhead-like 1 (Drosophila) |
|
affects expression | ISO | 2 | 10,091,792 | 10,142,412 | RGD:6480464 | CTD | |
| G | GRIA1 | glutamate receptor, ionotropic, AMPA 1 |
|
decreases expression | ISO | 5 | 152,870,084 | 153,193,429 | RGD:6480464 | CTD | |
| G | GRIA2 | glutamate receptor, ionotropic, AMPA 2 |
|
decreases expression | ISO | 4 | 158,141,736 | 158,287,227 | RGD:6480464 | CTD | |
| G | GRIK2 | glutamate receptor, ionotropic, kainate 2 |
|
decreases expression | ISO | 6 | 101,846,861 | 102,517,958 | RGD:6480464 | CTD | |
| G | GRIK5 | glutamate receptor, ionotropic, kainate 5 |
|
affects expression | ISO | 19 | 42,502,468 | 42,569,957 | RGD:6480464 | CTD | |
| G | GRIN1 | glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
decreases expression | ISO | 9 | 140,033,609 | 140,063,214 | RGD:6480464 | CTD | |
| G | GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
increases expression | ISO | 16 | 9,847,265 | 10,276,611 | RGD:6480464 | CTD | |
| G | H6PD | hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
|
increases expression | ISO | 1 | 9,294,863 | 9,331,396 | RGD:6480464 | CTD | |
| G | HAAO | 3-hydroxyanthranilate 3,4-dioxygenase |
|
multiple interactions | EXP | 2 | 42,994,229 | 43,019,751 | RGD:6480464 | CTD | |
| G | HACL1 | 2-hydroxyacyl-CoA lyase 1 |
|
increases expression | ISO | 3 | 15,602,239 | 15,643,130 | RGD:6480464 | CTD | |
| G | HADHB | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit |
|
affects expression | ISO | 2 | 26,467,616 | 26,513,333 | RGD:6480464 | CTD | |
| G | HADHB | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit |
|
increases expression | ISO | 2 | 26,467,616 | 26,513,333 | RGD:6480464 | CTD | |
| G | HAGH | hydroxyacylglutathione hydrolase |
|
increases expression | ISO | 16 | 1,859,104 | 1,877,195 | RGD:6480464 | CTD | |
| G | HAND2 | heart and neural crest derivatives expressed 2 |
|
affects expression | ISO | 4 | 174,447,652 | 174,451,378 | RGD:6480464 | CTD | |
| G | HAO2 | hydroxyacid oxidase 2 (long chain) |
|
affects expression | ISO | 1 | 119,911,402 | 119,936,751 | RGD:6480464 | CTD | |
| G | HAP1 | huntingtin-associated protein 1 |
|
affects expression | ISO | 17 | 39,878,891 | 39,890,898 | RGD:6480464 | CTD | |
| G | HAP1 | huntingtin-associated protein 1 |
|
increases expression | ISO | 17 | 39,878,891 | 39,890,898 | RGD:6480464 | CTD | |
| G | HAPLN3 | hyaluronan and proteoglycan link protein 3 |
|
affects expression | ISO | 15 | 89,420,519 | 89,438,770 | RGD:6480464 | CTD | |
| G | HAUS4 | HAUS augmin-like complex, subunit 4 |
|
affects expression | ISO | 14 | 23,415,437 | 23,426,351 | RGD:6480464 | CTD | |
| G | HAUS7 | HAUS augmin-like complex, subunit 7 |
|
affects expression | ISO | X | 152,713,123 | 152,760,983 | RGD:6480464 | CTD | |
| G | HAX1 | HCLS1 associated protein X-1 |
|
decreases expression | ISO | 1 | 154,245,039 | 154,248,351 | RGD:6480464 | CTD | |
| G | HBA1 | hemoglobin, alpha 1 |
|
multiple interactions | EXP | 16 | 226,679 | 227,520 | RGD:6480464 | CTD | |
| G | HBA2 | hemoglobin, alpha 2 |
|
increases expression | ISO | 16 | 222,846 | 223,709 | RGD:6480464 | CTD | |
| G | HBB | hemoglobin, beta |
|
multiple interactions | EXP | 11 | 5,246,696 | 5,248,301 | RGD:6480464 | CTD | |
| G | HBG2 | hemoglobin, gamma G |
|
affects expression | ISO | 11 | 5,274,421 | 5,276,011 | RGD:6480464 | CTD | |
| G | HBP1 | HMG-box transcription factor 1 |
|
increases expression | EXP | 7 | 106,809,406 | 106,842,974 | RGD:6480464 | CTD | |
| G | HBZ | hemoglobin, zeta |
|
affects expression | ISO | 16 | 202,854 | 204,504 | RGD:6480464 | CTD | |
| G | HBZ | hemoglobin, zeta |
|
multiple interactions | EXP | 16 | 202,854 | 204,504 | RGD:6480464 | CTD | |
| G | HCFC1R1 | host cell factor C1 regulator 1 (XPO1 dependent) |
|
multiple interactions | EXP | 16 | 3,072,626 | 3,074,287 | RGD:6480464 | CTD | |
| G | HCFC1R1 | host cell factor C1 regulator 1 (XPO1 dependent) |
|
increases expression | EXP | 16 | 3,072,626 | 3,074,287 | RGD:6480464 | CTD | |
| G | HCFC2 | host cell factor C2 |
|
increases expression | ISO | 12 | 104,458,236 | 104,500,302 | RGD:6480464 | CTD | |
| G | HCG22 | HLA complex group 22 (non-protein coding) |
|
multiple interactions | EXP | 6 | 31,021,227 | 31,027,667 | RGD:6480464 | CTD | |
| G | HCLS1 | hematopoietic cell-specific Lyn substrate 1 |
|
affects expression | ISO | 3 | 121,350,246 | 121,379,791 | RGD:6480464 | CTD | |
| G | HCN3 | hyperpolarization activated cyclic nucleotide-gated potassium channel 3 |
|
increases expression | ISO | 1 | 155,247,218 | 155,259,639 | RGD:6480464 | CTD | |
| G | HCST | hematopoietic cell signal transducer |
|
affects expression | ISO | 19 | 36,393,382 | 36,395,173 | RGD:6480464 | CTD | |
| G | HDAC1 | histone deacetylase 1 |
|
decreases activity | EXP | 1 | 32,757,708 | 32,799,224 | RGD:6480464 | CTD | |
| G | HDAC2 | histone deacetylase 2 |
|
multiple interactions | EXP | 6 | 114,257,320 | 114,292,359 | RGD:6480464 | CTD | |
| G | HDAC2 | histone deacetylase 2 |
|
decreases activity | EXP | 6 | 114,257,320 | 114,292,359 | RGD:6480464 | CTD | |
| G | HDAC2 | histone deacetylase 2 |
|
decreases expression | EXP | 6 | 114,257,320 | 114,292,359 | RGD:6480464 | CTD | |
| G | HDAC2 | histone deacetylase 2 |
|
increases degradation | EXP | 6 | 114,257,320 | 114,292,359 | RGD:6480464 | CTD | |
| G | HDAC3 | histone deacetylase 3 |
|
decreases activity | EXP | 5 | 141,000,443 | 141,016,423 | RGD:6480464 | CTD | |
| G | HDAC5 | histone deacetylase 5 |
|
affects expression | ISO | 17 | 42,154,121 | 42,201,014 | RGD:6480464 | CTD | |
| G | HDGF | hepatoma-derived growth factor |
|
decreases expression | EXP | 1 | 156,711,899 | 156,722,240 | RGD:6480464 | CTD | |
| G | HDGF | hepatoma-derived growth factor |
|
affects expression | ISO | 1 | 156,711,899 | 156,722,240 | RGD:6480464 | CTD | |
| G | HDGFL1 | hepatoma derived growth factor-like 1 |
|
multiple interactions | EXP | 6 | 22,569,678 | 22,570,750 | RGD:6480464 | CTD | |
| G | HDGFRP2 | hepatoma-derived growth factor-related protein 2 |
|
affects expression | ISO | 19 | 4,472,255 | 4,502,223 | RGD:6480464 | CTD | |
| G | HEATR2 | HEAT repeat containing 2 |
|
multiple interactions | EXP | 7 | 766,338 | 826,116 | RGD:6480464 | CTD | |
| G | HEATR5B | HEAT repeat containing 5B |
|
multiple interactions | EXP | 2 | 37,208,153 | 37,311,485 | RGD:6480464 | CTD | |
| G | HEBP1 | heme binding protein 1 |
|
multiple interactions | EXP | 12 | 13,127,798 | 13,153,243 | RGD:6480464 | CTD | |
| G | HEBP1 | heme binding protein 1 |
|
increases expression | ISO | 12 | 13,127,798 | 13,153,243 | RGD:6480464 | CTD | |
| G | HEBP1 | heme binding protein 1 |
|
increases expression | EXP | 12 | 13,127,798 | 13,153,243 | RGD:6480464 | CTD | |
| G | HEBP2 | heme binding protein 2 |
|
increases expression | EXP | 6 | 138,725,336 | 138,734,582 | RGD:6480464 | CTD | |
| G | HECA | headcase homolog (Drosophila) |
|
increases expression | EXP | 6 | 139,456,249 | 139,501,946 | RGD:6480464 | CTD | |
| G | HECTD3 | HECT domain containing E3 ubiquitin protein ligase 3 |
|
increases expression | EXP | 1 | 45,468,220 | 45,477,027 | RGD:6480464 | CTD | |
| G | HECTD3 | HECT domain containing E3 ubiquitin protein ligase 3 |
|
affects expression | ISO | 1 | 45,468,220 | 45,477,027 | RGD:6480464 | CTD | |
| G | HEG1 | heart development protein with EGF-like domains 1 |
|
affects expression | ISO | 3 | 124,684,554 | 124,774,802 | RGD:6480464 | CTD | |
| G | HEMGN | hemogen |
|
affects expression | ISO | 9 | 100,689,073 | 100,707,134 | RGD:6480464 | CTD | |
| G | HENMT1 | HEN1 methyltransferase homolog 1 (Arabidopsis) |
|
multiple interactions | EXP | 1 | 109,190,910 | 109,204,148 | RGD:6480464 | CTD | |
| G | HERPUD1 | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
|
affects expression | ISO | 16 | 56,965,748 | 56,977,793 | RGD:6480464 | CTD | |
| G | HEXB | hexosaminidase B (beta polypeptide) |
|
increases expression | EXP | 5 | 73,980,969 | 74,017,113 | RGD:6480464 | CTD | |
| G | HEXB | hexosaminidase B (beta polypeptide) |
|
affects expression | ISO | 5 | 73,980,969 | 74,017,113 | RGD:6480464 | CTD | |
| G | HEXIM2 | hexamethylene bis-acetamide inducible 2 |
|
affects expression | ISO | 17 | 43,238,264 | 43,247,406 | RGD:6480464 | CTD | |
| G | HEY2 | hairy/enhancer-of-split related with YRPW motif 2 |
|
increases expression | ISO | 6 | 126,070,732 | 126,082,415 | RGD:6480464 | CTD | |
| G | HFE | hemochromatosis |
|
multiple interactions | EXP | 6 | 26,087,509 | 26,095,469 | RGD:6480464 | CTD | |
| G | HGD | homogentisate 1,2-dioxygenase |
|
affects expression | ISO | 3 | 120,347,015 | 120,401,418 | RGD:6480464 | CTD | |
| G | HHEX | hematopoietically expressed homeobox |
|
affects expression | ISO | 10 | 94,449,681 | 94,455,408 | RGD:6480464 | CTD | |
| G | HIC2 | hypermethylated in cancer 2 |
|
affects expression | ISO | 22 | 21,771,693 | 21,805,752 | RGD:6480464 | CTD | |
| G | HIF1AN | hypoxia inducible factor 1, alpha subunit inhibitor |
|
affects expression | ISO | 10 | 102,295,641 | 102,313,681 | RGD:6480464 | CTD | |
| G | HLA-G | major histocompatibility complex, class I, G |
|
affects expression | ISO | 6 | 29,794,756 | 29,798,899 | RGD:6480464 | CTD | |
| G | HSD17B8 | hydroxysteroid (17-beta) dehydrogenase 8 |
|
increases expression | ISO | 6 | 33,172,414 | 33,174,608 | RGD:6480464 | CTD | |
| G | HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
decreases expression | EXP | 1 | 119,957,554 | 119,965,662 | RGD:6480464 | CTD | |
| G | HSD3B7 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
|
affects expression | ISO | 16 | 30,996,519 | 31,000,473 | RGD:6480464 | CTD | |
| G | HSD3B7 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
|
decreases expression | ISO | 16 | 30,996,519 | 31,000,473 | RGD:6480464 | CTD | |
| G | HSDL2 | hydroxysteroid dehydrogenase like 2 |
|
affects expression | ISO | 9 | 115,142,189 | 115,234,685 | RGD:6480464 | CTD | |
| G | HSDL2 | hydroxysteroid dehydrogenase like 2 |
|
decreases expression | ISO | 9 | 115,142,189 | 115,234,685 | RGD:6480464 | CTD | |
| G | HSDL2 | hydroxysteroid dehydrogenase like 2 |
|
increases expression | ISO | 9 | 115,142,189 | 115,234,685 | RGD:6480464 | CTD | |
| G | HSF1 | heat shock transcription factor 1 |
|
decreases expression | ISO | 8 | 145,515,270 | 145,538,385 | RGD:6480464 | CTD | |
| G | HSF1 | heat shock transcription factor 1 |
|
affects expression | ISO | 8 | 145,515,270 | 145,538,385 | RGD:6480464 | CTD | |
| G | HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
|
affects expression | ISO | 14 | 102,547,075 | 102,606,086 | RGD:6480464 | CTD | |
| G | HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
|
decreases expression | ISO | 14 | 102,547,075 | 102,606,086 | RGD:6480464 | CTD | |
| G | HSP90B1 | heat shock protein 90kDa beta (Grp94), member 1 |
|
affects expression | ISO | 12 | 104,324,112 | 104,341,708 | RGD:6480464 | CTD | |
| G | HSP90B1 | heat shock protein 90kDa beta (Grp94), member 1 |
|
multiple interactions | ISO | 12 | 104,324,112 | 104,341,708 | RGD:6480464 | CTD | |
| G | HSP90B1 | heat shock protein 90kDa beta (Grp94), member 1 |
|
increases expression | ISO | 12 | 104,324,112 | 104,341,708 | RGD:6480464 | CTD | |
| G | HSPA1A | heat shock 70kDa protein 1A |
|
increases expression | ISO | 6 | 31,783,291 | 31,785,719 | RGD:6480464 | CTD | |
| G | HSPA1A | heat shock 70kDa protein 1A |
|
increases expression | ISO | 6 | 31,783,291 | 31,785,719 | RGD:6480464 | CTD | |
| G | HSPA1B | heat shock 70kDa protein 1B |
|
increases expression | ISO | 6 | 31,795,512 | 31,798,031 | RGD:6480464 | CTD | |
| G | HSPA2 | heat shock 70kDa protein 2 |
|
decreases expression | ISO | 14 | 65,007,186 | 65,009,955 | RGD:6480464 | CTD | |
| G | HSPA2 | heat shock 70kDa protein 2 |
|
increases expression | ISO | 14 | 65,007,186 | 65,009,955 | RGD:6480464 | CTD | |
| G | HSPA4L | heat shock 70kDa protein 4-like |
|
affects expression | ISO | 4 | 128,703,453 | 128,754,522 | RGD:6480464 | CTD | |
| G | HSPA5 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
increases expression | ISO | 9 | 127,997,127 | 128,003,666 | RGD:6480464 | CTD | |
| G | HSPA5 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
affects expression | ISO | 9 | 127,997,127 | 128,003,666 | RGD:6480464 | CTD | |
| G | HSPA8 | heat shock 70kDa protein 8 |
|
multiple interactions | EXP | 11 | 122,928,200 | 122,932,901 | RGD:6480464 | CTD | |
| G | HSPA9 | heat shock 70kDa protein 9 (mortalin) |
|
multiple interactions | ISO | 5 | 137,890,571 | 137,911,318 | RGD:6480464 | CTD | |
| G | HSPB11 | heat shock protein family B (small), member 11 |
|
increases expression | ISO | 1 | 54,387,234 | 54,411,288 | RGD:6480464 | CTD | |
| G | HSPB2 | heat shock 27kDa protein 2 |
|
affects expression | ISO | 11 | 111,783,460 | 111,784,817 | RGD:6480464 | CTD | |
| G | HSPB6 | heat shock protein, alpha-crystallin-related, B6 |
|
affects expression | ISO | 19 | 36,245,467 | 36,247,930 | RGD:6480464 | CTD | |
| G | HSPBP1 | HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
|
affects expression | ISO | 19 | 55,773,591 | 55,791,751 | RGD:6480464 | CTD | |
| G | HSPD1 | heat shock 60kDa protein 1 (chaperonin) |
|
decreases expression | ISO | 2 | 198,351,308 | 198,364,998 | RGD:6480464 | CTD | |
| G | HSPH1 | heat shock 105kDa/110kDa protein 1 |
|
affects expression | ISO | 13 | 31,710,762 | 31,736,117 | RGD:6480464 | CTD | |
| G | HTATIP2 | HIV-1 Tat interactive protein 2, 30kDa |
|
affects expression | ISO | 11 | 20,385,231 | 20,405,329 | RGD:6480464 | CTD | |
| G | HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
|
affects expression | ISO | 6 | 78,171,948 | 78,173,120 | RGD:6480464 | CTD | |
| G | HTR3B | 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
|
affects expression | ISO | 11 | 113,775,518 | 113,817,283 | RGD:6480464 | CTD | |
| G | HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
|
increases expression | EXP | 5 | 147,830,595 | 148,033,739 | RGD:6480464 | CTD | |
| G | HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
|
affects expression | ISO | 5 | 147,830,595 | 148,033,739 | RGD:6480464 | CTD | |
| G | HTRA3 | HtrA serine peptidase 3 |
|
affects expression | ISO | 4 | 8,271,489 | 8,308,838 | RGD:6480464 | CTD | |
| G | HUNK | hormonally up-regulated Neu-associated kinase |
|
affects expression | ISO | 21 | 33,245,628 | 33,376,377 | RGD:6480464 | CTD | |
| G | HVCN1 | hydrogen voltage-gated channel 1 |
|
increases expression | ISO | 12 | 111,086,491 | 111,127,617 | RGD:6480464 | CTD | |
| G | HYAL1 | hyaluronoglucosaminidase 1 |
|
affects expression | ISO | 3 | 50,337,320 | 50,349,812 | RGD:6480464 | CTD | |
| G | HYAL3 | hyaluronoglucosaminidase 3 |
|
affects expression | ISO | 3 | 50,330,259 | 50,336,899 | RGD:6480464 | CTD | |
| G | HYDIN | HYDIN, axonemal central pair apparatus protein |
|
affects expression | ISO | 16 | 70,841,287 | 71,264,625 | RGD:6480464 | CTD | |
| G | HYI | hydroxypyruvate isomerase (putative) |
|
multiple interactions | EXP | 1 | 43,916,674 | 43,919,660 | RGD:6480464 | CTD | |
| G | ICA1L | islet cell autoantigen 1,69kDa-like |
|
affects expression | ISO | 2 | 203,637,873 | 203,736,371 | RGD:6480464 | CTD | |
| G | ICAM1 | intercellular adhesion molecule 1 |
|
multiple interactions | EXP | 19 | 10,381,517 | 10,397,291 | RGD:6480464 | CTD | |
| G | ICMT | isoprenylcysteine carboxyl methyltransferase |
|
multiple interactions | EXP | 1 | 6,281,253 | 6,296,044 | RGD:6480464 | CTD | |
| G | ICMT | isoprenylcysteine carboxyl methyltransferase |
|
increases expression | ISO | 1 | 6,281,253 | 6,296,044 | RGD:6480464 | CTD | |
| G | ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
|
increases expression | ISO | 20 | 30,193,086 | 30,194,318 | RGD:6480464 | CTD | |
| G | ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
|
affects expression | ISO | 2 | 8,822,113 | 8,824,583 | RGD:6480464 | CTD | |
| G | ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
|
increases expression | ISO | 2 | 8,822,113 | 8,824,583 | RGD:6480464 | CTD | |
| G | IDH2 | isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
decreases expression | EXP | 15 | 90,627,210 | 90,645,708 | RGD:6480464 | CTD | |
| G | IDH3A | isocitrate dehydrogenase 3 (NAD+) alpha |
|
affects expression | ISO | 15 | 78,441,719 | 78,462,884 | RGD:6480464 | CTD | |
| G | IDH3G | isocitrate dehydrogenase 3 (NAD+) gamma |
|
multiple interactions | EXP | X | 153,051,221 | 153,059,978 | RGD:6480464 | CTD | |
| G | IDI1 | isopentenyl-diphosphate delta isomerase 1 |
|
affects expression | ISO | 10 | 1,085,963 | 1,095,061 | RGD:6480464 | CTD | |
| G | IDI2 | isopentenyl-diphosphate delta isomerase 2 |
|
affects expression | ISO | 10 | 1,064,847 | 1,071,799 | RGD:6480464 | CTD | |
| G | IDS | iduronate 2-sulfatase |
|
affects expression | ISO | X | 148,560,295 | 148,586,884 | RGD:6480464 | CTD | |
| G | IER3 | immediate early response 3 |
|
affects expression | ISO | 6 | 30,710,976 | 30,712,327 | RGD:6480464 | CTD | |
| G | IER3 | immediate early response 3 |
|
increases expression | ISO | 6 | 30,710,976 | 30,712,327 | RGD:6480464 | CTD | |
| G | IER5 | immediate early response 5 |
|
increases expression | ISO | 1 | 181,057,638 | 181,059,979 | RGD:6480464 | CTD | |
| G | IFFO2 | intermediate filament family orphan 2 |
|
affects expression | ISO | 1 | 19,230,774 | 19,282,826 | RGD:6480464 | CTD | |
| G | IFI16 | interferon, gamma-inducible protein 16 |
|
affects expression | ISO | 1 | 158,979,682 | 159,024,945 | RGD:6480464 | CTD | |
| G | IFI27L1 | interferon, alpha-inducible protein 27-like 1 |
|
affects expression | ISO | 14 | 94,547,639 | 94,569,060 | RGD:6480464 | CTD | |
| G | IFI30 | interferon, gamma-inducible protein 30 |
|
increases expression | ISO | 19 | 18,284,579 | 18,288,927 | RGD:6480464 | CTD | |
| G | IFI30 | interferon, gamma-inducible protein 30 |
|
increases expression | EXP | 19 | 18,284,579 | 18,288,927 | RGD:6480464 | CTD | |
| G | IMPDH2 | IMP (inosine 5'-monophosphate) dehydrogenase 2 |
|
affects expression | ISO | 3 | 49,061,758 | 49,066,875 | RGD:6480464 | CTD | |
| G | INCA1 | inhibitor of CDK, cyclin A1 interacting protein 1 |
|
affects expression | ISO | 17 | 4,891,425 | 4,900,905 | RGD:6480464 | CTD | |
| G | ING1 | inhibitor of growth family, member 1 |
|
affects expression | ISO | 13 | 111,364,970 | 111,373,421 | RGD:6480464 | CTD | |
| G | ING3 | inhibitor of growth family, member 3 |
|
affects expression | ISO | 7 | 120,590,817 | 120,615,711 | RGD:6480464 | CTD | |
| G | ING4 | inhibitor of growth family, member 4 |
|
affects expression | ISO | 12 | 6,759,704 | 6,772,308 | RGD:6480464 | CTD | |
| G | ING5 | inhibitor of growth family, member 5 |
|
decreases expression | ISO | 2 | 242,641,456 | 242,668,896 | RGD:6480464 | CTD | |
| G | INHA | inhibin, alpha |
|
multiple interactions | ISO | 2 | 220,436,954 | 220,440,435 | RGD:6480464 | CTD | |
| G | INHBA | inhibin, beta A |
|
increases expression | EXP | 7 | 41,728,601 | 41,742,706 | RGD:6480464 | CTD | |
| G | INHBE | inhibin, beta E |
|
affects expression | ISO | 12 | 57,849,096 | 57,851,791 | RGD:6480464 | CTD | |
| G | INMT | indolethylamine N-methyltransferase |
|
affects expression | ISO | 7 | 30,791,751 | 30,797,218 | RGD:6480464 | CTD | |
| G | INO80C | INO80 complex subunit C |
|
affects expression | ISO | 18 | 33,048,291 | 33,077,955 | RGD:6480464 | CTD | |
| G | INO80E | INO80 complex subunit E |
|
multiple interactions | EXP | 16 | 30,007,531 | 30,017,112 | RGD:6480464 | CTD | |
| G | INO80E | INO80 complex subunit E |
|
affects expression | ISO | 16 | 30,007,531 | 30,017,112 | RGD:6480464 | CTD | |
| G | INPP1 | inositol polyphosphate-1-phosphatase |
|
affects expression | ISO | 2 | 191,208,196 | 191,236,391 | RGD:6480464 | CTD | |
| G | INPP5A | inositol polyphosphate-5-phosphatase, 40kDa |
|
affects expression | ISO | 10 | 134,351,353 | 134,596,984 | RGD:6480464 | CTD | |
| G | INSC | inscuteable homolog (Drosophila) |
|
affects expression | ISO | 11 | 15,133,970 | 15,268,754 | RGD:6480464 | CTD | |
| G | INSIG1 | insulin induced gene 1 |
|
affects expression | ISO | 7 | 155,089,486 | 155,101,945 | RGD:6480464 | CTD | |
| G | INSIG2 | insulin induced gene 2 |
|
affects expression | ISO | 2 | 118,846,050 | 118,867,597 | RGD:6480464 | CTD | |
| G | INSL6 | insulin-like 6 |
|
increases expression | ISO | 9 | 5,163,863 | 5,185,618 | RGD:6480464 | CTD | |
| G | INSR | insulin receptor |
|
affects expression | ISO | 19 | 7,112,266 | 7,294,011 | RGD:6480464 | CTD | |
| G | INSRR | insulin receptor-related receptor |
|
affects expression | ISO | 1 | 156,810,665 | 156,828,712 | RGD:6480464 | CTD | |
| G | INTS12 | integrator complex subunit 12 |
|
decreases expression | ISO | 4 | 106,603,784 | 106,629,881 | RGD:6480464 | CTD | |
| G | INTS2 | integrator complex subunit 2 |
|
affects expression | ISO | 17 | 59,942,728 | 60,005,377 | RGD:6480464 | CTD | |
| G | INTS2 | integrator complex subunit 2 |
|
decreases expression | ISO | 17 | 59,942,728 | 60,005,377 | RGD:6480464 | CTD | |
| G | INTS9 | integrator complex subunit 9 |
|
affects expression | ISO | 8 | 28,625,175 | 28,747,698 | RGD:6480464 | CTD | |
| G | INTU | inturned planar cell polarity protein |
|
increases expression | ISO | 4 | 128,554,087 | 128,637,934 | RGD:6480464 | CTD | |
| G | IP6K1 | inositol hexakisphosphate kinase 1 |
|
decreases expression | ISO | 3 | 49,761,728 | 49,823,973 | RGD:6480464 | CTD | |
| G | IPO13 | importin 13 |
|
affects expression | ISO | 1 | 44,412,478 | 44,433,694 | RGD:6480464 | CTD | |
| G | IPO4 | importin 4 |
|
affects expression | ISO | 14 | 24,649,425 | 24,658,124 | RGD:6480464 | CTD | |
| G | IPO4 | importin 4 |
|
decreases expression | EXP | 14 | 24,649,425 | 24,658,124 | RGD:6480464 | CTD | |
| G | IPO7 | importin 7 |
|
affects expression | ISO | 11 | 9,406,169 | 9,469,674 | RGD:6480464 | CTD | |
| G | IPO8 | importin 8 |
|
affects expression | ISO | 12 | 30,781,915 | 30,848,929 | RGD:6480464 | CTD | |
| G | IPPK | inositol 1,3,4,5,6-pentakisphosphate 2-kinase |
|
affects expression | ISO | 9 | 95,375,466 | 95,432,547 | RGD:6480464 | CTD | |
| G | IRAK1 | interleukin-1 receptor-associated kinase 1 |
|
decreases expression | EXP | X | 153,275,957 | 153,285,342 | RGD:6480464 | CTD | |
| G | IRAK2 | interleukin-1 receptor-associated kinase 2 |
|
affects expression | ISO | 3 | 10,206,563 | 10,285,427 | RGD:6480464 | CTD | |
| G | IRF5 | interferon regulatory factor 5 |
|
affects expression | ISO | 7 | 128,577,994 | 128,590,089 | RGD:6480464 | CTD | |
| G | IRF6 | interferon regulatory factor 6 |
|
increases expression | ISO | 1 | 209,958,968 | 209,979,520 | RGD:6480464 | CTD | |
| G | IRF7 | interferon regulatory factor 7 |
|
multiple interactions | EXP | 11 | 612,555 | 615,999 | RGD:6480464 | CTD | |
| G | IRGC | immunity-related GTPase family, cinema |
|
affects expression | ISO | 19 | 44,220,214 | 44,224,173 | RGD:6480464 | CTD | |
| G | IRGM | immunity-related GTPase family, M |
|
affects expression | ISO | 5 | 150,226,085 | 150,228,231 | RGD:6480464 | CTD | |
| G | IRS3P | insulin receptor substrate 3, pseudogene |
|
affects expression | ISO | 7 | 100,162,878 | 100,167,751 | RGD:6480464 | CTD | |
| G | IRX3 | iroquois homeobox 3 |
|
multiple interactions | EXP | 16 | 54,317,212 | 54,320,378 | RGD:6480464 | CTD | |
| G | ISCA2 | iron-sulfur cluster assembly 2 homolog (S. cerevisiae) |
|
increases expression | EXP | 14 | 74,960,450 | 74,962,271 | RGD:6480464 | CTD | |
| G | ISCU | iron-sulfur cluster scaffold homolog (E. coli) |
|
affects expression | ISO | 12 | 108,956,294 | 108,963,160 | RGD:6480464 | CTD | |
| G | ISL1 | ISL LIM homeobox 1 |
|
affects expression | ISO | 5 | 50,678,958 | 50,690,564 | RGD:6480464 | CTD | |
| G | ISYNA1 | inositol-3-phosphate synthase 1 |
|
increases expression | EXP | 19 | 18,545,198 | 18,549,111 | RGD:6480464 | CTD | |
| G | ITFG2 | integrin alpha FG-GAP repeat containing 2 |
|
decreases expression | ISO | 12 | 2,921,787 | 2,934,237 | RGD:6480464 | CTD | |
| G | ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
|
increases expression | EXP | 5 | 52,285,156 | 52,390,609 | RGD:6480464 | CTD | |
| G | ITGA9 | integrin, alpha 9 |
|
affects expression | ISO | 3 | 37,493,813 | 37,861,281 | RGD:6480464 | CTD | |
| G | ITGAE | integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide) |
|
affects expression | ISO | 17 | 3,617,919 | 3,704,537 | RGD:6480464 | CTD | |
| G | ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) |
|
multiple interactions | EXP | 16 | 31,271,288 | 31,344,213 | RGD:6480464 | CTD | |
| G | ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) |
|
affects expression | ISO | 16 | 31,271,288 | 31,344,213 | RGD:6480464 | CTD | |
| G | ITIH5 | inter-alpha-trypsin inhibitor heavy chain family, member 5 |
|
increases expression | ISO | 10 | 7,601,232 | 7,708,961 | RGD:6480464 | CTD | |
| G | ITPA | inosine triphosphatase (nucleoside triphosphate pyrophosphatase) |
|
affects expression | ISO | 20 | 3,189,514 | 3,204,516 | RGD:6480464 | CTD | |
| G | ITPK1 | inositol-tetrakisphosphate 1-kinase |
|
increases expression | ISO | 14 | 93,403,259 | 93,582,263 | RGD:6480464 | CTD | |
| G | ITPK1-AS1 | ITPK1 antisense RNA 1 |
|
multiple interactions | EXP | 14 | 93,533,797 | 93,538,497 | RGD:6480464 | CTD | |
| G | ITPKA | inositol-trisphosphate 3-kinase A |
|
increases expression | ISO | 15 | 41,786,056 | 41,795,757 | RGD:6480464 | CTD | |
| G | ITPR3 | inositol 1,4,5-trisphosphate receptor, type 3 |
|
increases expression | EXP | 6 | 33,589,156 | 33,664,351 | RGD:6480464 | CTD | |
| G | ITSN1 | intersectin 1 (SH3 domain protein) |
|
multiple interactions | EXP | 21 | 35,014,784 | 35,261,609 | RGD:6480464 | CTD | |
| G | ITSN2 | intersectin 2 |
|
multiple interactions | EXP | 2 | 24,425,735 | 24,583,397 | RGD:6480464 | CTD | |
| G | IVD | isovaleryl-CoA dehydrogenase |
|
decreases expression | ISO | 15 | 40,697,686 | 40,713,512 | RGD:6480464 | CTD | |
| G | IVL | involucrin |
|
affects expression | ISO | 1 | 152,881,039 | 152,884,362 | RGD:6480464 | CTD | |
| G | IVNS1ABP | influenza virus NS1A binding protein |
|
decreases expression | EXP | 1 | 185,265,520 | 185,286,461 | RGD:6480464 | CTD | |
| G | IYD | iodotyrosine deiodinase |
|
affects expression | ISO | 6 | 150,690,028 | 150,725,765 | RGD:6480464 | CTD | |
| G | KIAA0020 | KIAA0020 |
|
affects expression | ISO | 9 | 2,804,152 | 2,844,130 | RGD:6480464 | CTD | |
| G | KIAA0020 | KIAA0020 |
|
decreases expression | ISO | 9 | 2,804,152 | 2,844,130 | RGD:6480464 | CTD | |
| G | KIF19 | kinesin family member 19 |
|
affects expression | ISO | 17 | 72,322,351 | 72,351,959 | RGD:6480464 | CTD | |
| G | KIF1A | kinesin family member 1A |
|
affects expression | ISO | 2 | 241,653,181 | 241,759,725 | RGD:6480464 | CTD | |
| G | KIF20B | kinesin family member 20B |
|
decreases expression | EXP | 10 | 91,461,367 | 91,534,700 | RGD:6480464 | CTD | |
| G | KIF21B | kinesin family member 21B |
|
increases expression | EXP | 1 | 200,938,514 | 200,992,828 | RGD:6480464 | CTD | |
| G | KIF2C | kinesin family member 2C |
|
decreases expression | ISO | 1 | 45,205,490 | 45,233,439 | RGD:6480464 | CTD | |
| G | KIF3C | kinesin family member 3C |
|
affects expression | ISO | 2 | 26,149,455 | 26,205,443 | RGD:6480464 | CTD | |
| G | KIF5C | kinesin family member 5C |
|
increases expression | EXP | 2 2 |
149,793,796 149,632,792 |
149,883,273 149,686,923 |
RGD:6480464 | CTD | |
| G | KIF9 | kinesin family member 9 |
|
affects expression | ISO | 3 | 47,269,516 | 47,324,337 | RGD:6480464 | CTD | |
| G | KIF9 | kinesin family member 9 |
|
increases expression | ISO | 3 | 47,269,516 | 47,324,337 | RGD:6480464 | CTD | |
| G | KIFC2 | kinesin family member C2 |
|
affects expression | ISO | 8 | 145,691,738 | 145,699,499 | RGD:6480464 | CTD | |
| G | KIFC2 | kinesin family member C2 |
|
increases expression | EXP | 8 | 145,691,738 | 145,699,499 | RGD:6480464 | CTD | |
| G | KIR3DL2 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 |
|
affects expression | ISO | 19 | 55,361,898 | 55,378,670 | RGD:6480464 | CTD | |
| G | KIRREL2 | kin of IRRE like 2 (Drosophila) |
|
affects expression | ISO | 19 | 36,347,810 | 36,358,048 | RGD:6480464 | CTD | |
| G | KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
increases expression | EXP | 4 | 55,524,095 | 55,606,881 | RGD:6480464 | CTD | |
| G | KITLG | KIT ligand |
|
affects expression | ISO | 12 | 88,886,570 | 88,974,250 | RGD:6480464 | CTD | |
| G | KITLG | KIT ligand |
|
increases expression | EXP | 12 | 88,886,570 | 88,974,250 | RGD:6480464 | CTD | |
| G | KLB | klotho beta |
|
increases expression | EXP | 4 | 39,408,473 | 39,453,153 | RGD:6480464 | CTD | |
| G | KLF13 | Kruppel-like factor 13 |
|
affects expression | ISO | 15 | 31,619,083 | 31,670,102 | RGD:6480464 | CTD | |
| G | KLF3 | Kruppel-like factor 3 (basic) |
|
decreases expression | ISO | 4 | 38,665,790 | 38,703,129 | RGD:6480464 | CTD | |
| G | KLF5 | Kruppel-like factor 5 (intestinal) |
|
increases expression | ISO | 13 | 73,633,142 | 73,651,676 | RGD:6480464 | CTD | |
| G | KLF6 | Kruppel-like factor 6 |
|
multiple interactions | EXP | 10 | 3,818,188 | 3,827,473 | RGD:6480464 | CTD | |
| G | KLF9 | Kruppel-like factor 9 |
|
increases expression | EXP | 9 | 72,999,513 | 73,029,573 | RGD:6480464 | CTD | |
| G | KLHDC4 | kelch domain containing 4 |
|
affects expression | ISO | 16 | 87,741,418 | 87,799,598 | RGD:6480464 | CTD | |
| G | KLHDC7A | kelch domain containing 7A |
|
affects expression | ISO | 1 | 18,807,424 | 18,812,493 | RGD:6480464 | CTD | |
| G | KLHDC8B | kelch domain containing 8B |
|
increases expression | ISO | 3 | 49,209,018 | 49,213,919 | RGD:6480464 | CTD | |
| G | KLHL11 | kelch-like family member 11 |
|
affects expression | ISO | 17 | 40,009,799 | 40,021,629 | RGD:6480464 | CTD | |
| G | KLHL13 | kelch-like family member 13 |
|
affects expression | ISO | X | 117,031,776 | 117,251,303 | RGD:6480464 | CTD | |
| G | KLHL23 | kelch-like family member 23 |
|
affects expression | ISO | 2 | 170,590,356 | 170,608,396 | RGD:6480464 | CTD | |
| G | KLHL23 | kelch-like family member 23 |
|
multiple interactions | EXP | 2 | 170,590,356 | 170,608,396 | RGD:6480464 | CTD | |
| G | KLHL26 | kelch-like family member 26 |
|
increases expression | ISO | 19 | 18,747,838 | 18,781,302 | RGD:6480464 | CTD | |
| G | KLHL26 | kelch-like family member 26 |
|
increases expression | EXP | 19 | 18,747,838 | 18,781,302 | RGD:6480464 | CTD | |
| G | KLHL29 | kelch-like family member 29 |
|
increases expression | EXP | 2 | 23,608,298 | 23,931,483 | RGD:6480464 | CTD | |
| G | KLHL29 | kelch-like family member 29 |
|
affects expression | ISO | 2 | 23,608,298 | 23,931,483 | RGD:6480464 | CTD | |
| G | KLHL42 | kelch-like family member 42 |
|
decreases expression | EXP | 12 | 27,933,187 | 27,955,973 | RGD:6480464 | CTD | |
| G | KLHL5 | kelch-like family member 5 |
|
increases expression | EXP | 4 | 39,046,451 | 39,127,853 | RGD:6480464 | CTD | |
| G | KLHL5 | kelch-like family member 5 |
|
increases expression | ISO | 4 | 39,046,451 | 39,127,853 | RGD:6480464 | CTD | |
| G | KLHL8 | kelch-like family member 8 |
|
increases expression | EXP | 4 | 88,082,214 | 88,141,674 | RGD:6480464 | CTD | |
| G | KLHL9 | kelch-like family member 9 |
|
multiple interactions | EXP | 9 | 21,331,018 | 21,335,429 | RGD:6480464 | CTD | |
| G | KLK9 | kallikrein-related peptidase 9 |
|
affects expression | ISO | 19 | 51,505,769 | 51,512,890 | RGD:6480464 | CTD | |
| G | KLRAP1 | killer cell lectin-like receptor subfamily A pseudogene 1 |
|
affects expression | ISO | 12 | 10,741,077 | 10,752,434 | RGD:6480464 | CTD | |
| G | KLRG2 | killer cell lectin-like receptor subfamily G, member 2 |
|
increases expression | ISO | 7 | 139,138,088 | 139,168,457 | RGD:6480464 | CTD | |
| G | KNG1 | kininogen 1 |
|
affects expression | ISO | 3 | 186,435,098 | 186,462,199 | RGD:6480464 | CTD | |
| G | KNTC1 | kinetochore associated 1 |
|
affects expression | ISO | 12 | 123,011,809 | 123,110,947 | RGD:6480464 | CTD | |
| G | KPNA1 | karyopherin alpha 1 (importin alpha 5) |
|
decreases expression | ISO | 3 | 122,140,748 | 122,233,786 | RGD:6480464 | CTD | |
| G | KPNA2 | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) |
|
affects expression | ISO | 17 | 66,031,848 | 66,042,970 | RGD:6480464 | CTD | |
| G | KPNB1 | karyopherin (importin) beta 1 |
|
decreases expression | EXP | 17 | 45,727,275 | 45,761,004 | RGD:6480464 | CTD | |
| G | KREMEN2 | kringle containing transmembrane protein 2 |
|
increases expression | ISO | 16 | 3,014,217 | 3,018,384 | RGD:6480464 | CTD | |
| G | KRT17 | keratin 17 |
|
multiple interactions | EXP | 17 | 39,775,692 | 39,780,882 | RGD:6480464 | CTD | |
| G | KRT18 | keratin 18 |
|
increases expression | ISO | 12 | 53,342,655 | 53,346,685 | RGD:6480464 | CTD | |
| G | KRT18 | keratin 18 |
|
affects expression | ISO | 12 | 53,342,655 | 53,346,685 | RGD:6480464 | CTD | |
| G | KRT23 | keratin 23 (histone deacetylase inducible) |
|
affects expression | ISO | 17 | 39,078,952 | 39,093,836 | RGD:6480464 | CTD | |
| G | KRT24 | keratin 24 |
|
affects expression | ISO | 17 | 38,854,243 | 38,860,002 | RGD:6480464 | CTD | |
| G | KRT33A | keratin 33A |
|
affects expression | ISO | 17 | 39,502,344 | 39,507,064 | RGD:6480464 | CTD | |
| G | KRT6B | keratin 6B |
|
affects expression | ISO | 12 | 52,840,435 | 52,845,910 | RGD:6480464 | CTD | |
| G | KRT7 | keratin 7 |
|
affects expression | ISO | 12 | 52,626,954 | 52,642,709 | RGD:6480464 | CTD | |
| G | KRT84 | keratin 84 |
|
affects expression | ISO | 12 | 52,771,596 | 52,779,417 | RGD:6480464 | CTD | |
| G | KRTAP19-5 | keratin associated protein 19-5 |
|
affects expression | ISO | 21 | 31,874,190 | 31,874,408 | RGD:6480464 | CTD | |
| G | KRTAP4-7 | keratin associated protein 4-7 |
|
multiple interactions | EXP | 17 | 39,240,459 | 39,241,396 | RGD:6480464 | CTD | |
| G | KRTAP5-5 | keratin associated protein 5-5 |
|
affects expression | ISO | 11 | 1,651,033 | 1,652,160 | RGD:6480464 | CTD | |
| G | KTI12 | KTI12 homolog, chromatin associated (S. cerevisiae) |
|
affects expression | ISO | 1 | 52,497,777 | 52,499,472 | RGD:6480464 | CTD | |
| G | KYNU | kynureninase |
|
affects expression | ISO | 2 | 143,635,195 | 143,799,885 | RGD:6480464 | CTD | |
| G | LACTB | lactamase, beta |
|
increases expression | EXP | 15 | 63,413,999 | 63,434,260 | RGD:6480464 | CTD | |
| G | LACTB | lactamase, beta |
|
increases expression | ISO | 15 | 63,413,999 | 63,434,260 | RGD:6480464 | CTD | |
| G | LAGE3 | L antigen family, member 3 |
|
affects expression | ISO | X | 153,705,241 | 153,707,596 | RGD:6480464 | CTD | |
| G | LAMP3 | lysosomal-associated membrane protein 3 |
|
increases expression | EXP | 3 | 182,840,003 | 182,880,667 | RGD:6480464 | CTD | |
| G | LANCL1 | LanC lantibiotic synthetase component C-like 1 (bacterial) |
|
affects expression | ISO | 2 | 211,295,973 | 211,341,499 | RGD:6480464 | CTD | |
| G | LPIN3 | lipin 3 |
|
multiple interactions | EXP | 20 | 39,969,560 | 39,989,222 | RGD:6480464 | CTD | |
| G | LPP | LIM domain containing preferred translocation partner in lipoma |
|
multiple interactions | EXP | 3 | 187,871,663 | 188,608,460 | RGD:6480464 | CTD | |
| G | LPXN | leupaxin |
|
affects expression | ISO | 11 | 58,294,344 | 58,345,639 | RGD:6480464 | CTD | |
| G | LRAT | lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) |
|
affects expression | ISO | 4 | 155,665,163 | 155,674,270 | RGD:6480464 | CTD | |
| G | LRCH2 | leucine-rich repeats and calponin homology (CH) domain containing 2 |
|
increases expression | EXP | X | 114,345,179 | 114,468,635 | RGD:6480464 | CTD | |
| G | LRFN1 | leucine rich repeat and fibronectin type III domain containing 1 |
|
multiple interactions | EXP | 19 | 39,797,457 | 39,805,976 | RGD:6480464 | CTD | |
| G | LRFN3 | leucine rich repeat and fibronectin type III domain containing 3 |
|
affects expression | ISO | 19 | 36,428,022 | 36,436,097 | RGD:6480464 | CTD | |
| G | LRIG1 | leucine-rich repeats and immunoglobulin-like domains 1 |
|
increases expression | EXP | 3 | 66,429,221 | 66,550,845 | RGD:6480464 | CTD | |
| G | LRIG1 | leucine-rich repeats and immunoglobulin-like domains 1 |
|
affects expression | ISO | 3 | 66,429,221 | 66,550,845 | RGD:6480464 | CTD | |
| G | LRMP | lymphoid-restricted membrane protein |
|
affects expression | ISO | 12 | 25,205,181 | 25,261,269 | RGD:6480464 | CTD | |
| G | LRP10 | low density lipoprotein receptor-related protein 10 |
|
multiple interactions | EXP | 14 | 23,340,960 | 23,347,293 | RGD:6480464 | CTD | |
| G | LRP10 | low density lipoprotein receptor-related protein 10 |
|
increases expression | EXP | 14 | 23,340,960 | 23,347,293 | RGD:6480464 | CTD | |
| G | LRP12 | low density lipoprotein receptor-related protein 12 |
|
affects expression | ISO | 8 | 105,501,459 | 105,601,252 | RGD:6480464 | CTD | |
| G | LRP3 | low density lipoprotein receptor-related protein 3 |
|
affects expression | ISO | 19 | 33,685,599 | 33,699,773 | RGD:6480464 | CTD | |
| G | LRPPRC | leucine-rich pentatricopeptide repeat containing |
|
affects expression | ISO | 2 | 44,113,363 | 44,223,144 | RGD:6480464 | CTD | |
| G | LRR1 | leucine rich repeat protein 1 |
|
increases expression | ISO | 14 | 50,065,415 | 50,081,390 | RGD:6480464 | CTD | |
| G | LRRC16A | leucine rich repeat containing 16A |
|
affects expression | ISO | 6 | 25,279,656 | 25,620,758 | RGD:6480464 | CTD | |
| G | LRRC2 | leucine rich repeat containing 2 |
|
decreases expression | ISO | 3 | 46,556,876 | 46,608,040 | RGD:6480464 | CTD | |
| G | LRRC26 | leucine rich repeat containing 26 |
|
affects expression | ISO | 9 | 140,063,210 | 140,064,491 | RGD:6480464 | CTD | |
| G | LRRC28 | leucine rich repeat containing 28 |
|
affects expression | ISO | 15 | 99,791,652 | 99,926,498 | RGD:6480464 | CTD | |
| G | LRRC34 | leucine rich repeat containing 34 |
|
increases expression | ISO | 3 | 169,511,216 | 169,530,574 | RGD:6480464 | CTD | |
| G | LRRC34 | leucine rich repeat containing 34 |
|
decreases expression | ISO | 3 | 169,511,216 | 169,530,574 | RGD:6480464 | CTD | |
| G | LRRC40 | leucine rich repeat containing 40 |
|
multiple interactions | EXP | 1 | 70,610,485 | 70,671,361 | RGD:6480464 | CTD | |
| G | LRRC41 | leucine rich repeat containing 41 |
|
affects expression | ISO | 1 | 46,744,072 | 46,769,038 | RGD:6480464 | CTD | |
| G | LRRC59 | leucine rich repeat containing 59 |
|
affects expression | ISO | 17 | 48,458,594 | 48,474,914 | RGD:6480464 | CTD | |
| G | LRRC8D | leucine rich repeat containing 8 family, member D |
|
affects expression | ISO | 1 | 90,286,573 | 90,401,991 | RGD:6480464 | CTD | |
| G | LRRC8E | leucine rich repeat containing 8 family, member E |
|
multiple interactions | EXP | 19 | 7,953,390 | 7,966,908 | RGD:6480464 | CTD | |
| G | LRRN1 | leucine rich repeat neuronal 1 |
|
increases expression | ISO | 3 | 3,841,121 | 3,889,387 | RGD:6480464 | CTD | |
| G | LRRTM2 | leucine rich repeat transmembrane neuronal 2 |
|
affects expression | ISO | 5 | 138,205,079 | 138,211,057 | RGD:6480464 | CTD | |
| G | LRRTM4 | leucine rich repeat transmembrane neuronal 4 |
|
affects expression | ISO | 2 | 76,974,849 | 77,749,502 | RGD:6480464 | CTD | |
| G | LRSAM1 | leucine rich repeat and sterile alpha motif containing 1 |
|
affects expression | ISO | 9 | 130,213,765 | 130,265,780 | RGD:6480464 | CTD | |
| G | LSAMP | limbic system-associated membrane protein |
|
affects expression | ISO | 3 | 115,521,210 | 116,164,385 | RGD:6480464 | CTD | |
| G | LSG1 | large subunit GTPase 1 homolog (S. cerevisiae) |
|
affects expression | ISO | 3 | 194,361,517 | 194,393,206 | RGD:6480464 | CTD | |
| G | LSM10 | LSM10, U7 small nuclear RNA associated |
|
affects expression | ISO | 1 | 36,859,031 | 36,863,493 | RGD:6480464 | CTD | |
| G | LSM12 | LSM12 homolog (S. cerevisiae) |
|
affects expression | ISO | 17 | 42,112,003 | 42,144,987 | RGD:6480464 | CTD | |
| G | LSMD1 | LSM domain containing 1 |
|
multiple interactions | EXP | 17 | 7,760,003 | 7,761,172 | RGD:6480464 | CTD | |
| G | LSS | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
|
affects expression | ISO | 21 | 47,608,360 | 47,648,738 | RGD:6480464 | CTD | |
| G | LTB4R2 | leukotriene B4 receptor 2 |
|
affects expression | ISO | 14 | 24,779,357 | 24,781,259 | RGD:6480464 | CTD | |
| G | LTV1 | LTV1 homolog (S. cerevisiae) |
|
affects expression | ISO | 6 | 144,164,508 | 144,184,943 | RGD:6480464 | CTD | |
| G | LUM | lumican |
|
increases expression | EXP | 12 | 91,497,232 | 91,505,542 | RGD:6480464 | CTD | |
| G | LUZP1 | leucine zipper protein 1 |
|
decreases expression | ISO | 1 | 23,410,516 | 23,495,351 | RGD:6480464 | CTD | |
| G | LY6D | lymphocyte antigen 6 complex, locus D |
|
affects expression | ISO | 8 | 143,866,298 | 143,868,008 | RGD:6480464 | CTD | |
| G | LY6G6D | lymphocyte antigen 6 complex, locus G6D |
|
affects expression | ISO | 6 | 31,683,133 | 31,685,581 | RGD:6480464 | CTD | |
| G | LY75 | lymphocyte antigen 75 |
|
increases expression | EXP | 2 | 160,659,866 | 160,761,267 | RGD:6480464 | CTD | |
| G | LY86 | lymphocyte antigen 86 |
|
multiple interactions | EXP | 6 | 6,588,934 | 6,655,216 | RGD:6480464 | CTD | |
| G | LY86 | lymphocyte antigen 86 |
|
affects expression | ISO | 6 | 6,588,934 | 6,655,216 | RGD:6480464 | CTD | |
| G | LYNX1 | Ly6/neurotoxin 1 |
|
increases expression | ISO | 8 | 143,845,756 | 143,859,640 | RGD:6480464 | CTD | |
| G | LYPD5 | LY6/PLAUR domain containing 5 |
|
affects expression | ISO | 19 | 44,300,079 | 44,324,808 | RGD:6480464 | CTD | |
| G | LYPLAL1 | lysophospholipase-like 1 |
|
affects expression | ISO | 1 | 219,347,192 | 219,386,207 | RGD:6480464 | CTD | |
| G | MACROD1 | MACRO domain containing 1 |
|
affects expression | ISO | 11 | 63,766,030 | 63,933,585 | RGD:6480464 | CTD | |
| G | MAD2L1BP | MAD2L1 binding protein |
|
affects expression | ISO | 6 | 43,597,279 | 43,608,689 | RGD:6480464 | CTD | |
| G | MAD2L2 | MAD2 mitotic arrest deficient-like 2 (yeast) |
|
increases expression | ISO | 1 | 11,734,537 | 11,751,678 | RGD:6480464 | CTD | |
| G | MAFB | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) |
|
affects expression | ISO | 20 | 39,314,515 | 39,317,876 | RGD:6480464 | CTD | |
| G | MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) |
|
affects expression | ISO | 17 | 79,876,145 | 79,885,587 | RGD:6480464 | CTD | |
| G | MAGEA10 | melanoma antigen family A, 10 |
|
affects expression | ISO | X | 151,301,782 | 151,307,050 | RGD:6480464 | CTD | |
| G | MAGED2 | melanoma antigen family D, 2 |
|
affects expression | ISO | X | 54,834,171 | 54,842,445 | RGD:6480464 | CTD | |
| G | MAGEE1 | melanoma antigen family E, 1 |
|
increases expression | ISO | X | 75,648,046 | 75,651,746 | RGD:6480464 | CTD | |
| G | MAGT1 | magnesium transporter 1 |
|
affects expression | ISO | X | 77,081,861 | 77,151,065 | RGD:6480464 | CTD | |
| G | MAL2 | mal, T-cell differentiation protein 2 (gene/pseudogene) |
|
affects expression | ISO | 8 | 120,220,610 | 120,257,913 | RGD:6480464 | CTD | |
| G | MAN2A1 | mannosidase, alpha, class 2A, member 1 |
|
affects expression | ISO | 5 | 109,025,156 | 109,203,429 | RGD:6480464 | CTD | |
| G | MAN2A2 | mannosidase, alpha, class 2A, member 2 |
|
affects expression | ISO | 15 | 91,447,420 | 91,465,815 | RGD:6480464 | CTD | |
| G | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 |
|
affects expression | ISO | 6 | 136,878,187 | 137,113,656 | RGD:6480464 | CTD | |
| G | MEAF6 | MYST/Esa1-associated factor 6 |
|
decreases expression | ISO | 1 | 37,955,561 | 37,980,420 | RGD:6480464 | CTD | |
| G | MECP2 | methyl CpG binding protein 2 (Rett syndrome) |
|
multiple interactions | ISO | X | 153,287,264 | 153,363,188 | RGD:6480464 | CTD | |
| G | MECR | mitochondrial trans-2-enoyl-CoA reductase |
|
affects expression | ISO | 1 | 29,519,385 | 29,557,454 | RGD:6480464 | CTD | |
| G | MED11 | mediator complex subunit 11 |
|
decreases expression | ISO | 17 | 4,634,723 | 4,636,902 | RGD:6480464 | CTD | |
| G | MED12L | mediator complex subunit 12-like |
|
affects expression | ISO | 3 | 150,804,676 | 151,154,465 | RGD:6480464 | CTD | |
| G | MED14 | mediator complex subunit 14 |
|
affects expression | ISO | X | 40,508,795 | 40,594,804 | RGD:6480464 | CTD | |
| G | MED18 | mediator complex subunit 18 |
|
affects expression | ISO | 1 | 28,655,513 | 28,662,478 | RGD:6480464 | CTD | |
| G | MED24 | mediator complex subunit 24 |
|
affects expression | ISO | 17 | 38,175,350 | 38,210,889 | RGD:6480464 | CTD | |
| G | MED8 | mediator complex subunit 8 |
|
multiple interactions | EXP | 1 | 43,849,588 | 43,855,483 | RGD:6480464 | CTD | |
| G | MEF2C | myocyte enhancer factor 2C |
|
increases expression | EXP | 5 | 88,014,058 | 88,199,922 | RGD:6480464 | CTD | |
| G | MEF2D | myocyte enhancer factor 2D |
|
affects expression | ISO | 1 | 156,433,519 | 156,470,529 | RGD:6480464 | CTD | |
| G | MEGF11 | multiple EGF-like-domains 11 |
|
affects expression | ISO | 15 | 66,187,634 | 66,546,075 | RGD:6480464 | CTD | |
| G | MEIG1 | meiosis expressed gene 1 homolog (mouse) |
|
increases expression | ISO | 10 | 15,001,438 | 15,014,850 | RGD:6480464 | CTD | |
| G | MEN1 | multiple endocrine neoplasia I |
|
affects expression | ISO | 11 | 64,570,986 | 64,578,766 | RGD:6480464 | CTD | |
| G | MEN1 | multiple endocrine neoplasia I |
|
increases expression | ISO | 11 | 64,570,986 | 64,578,766 | RGD:6480464 | CTD | |
| G | MEOX2 | mesenchyme homeobox 2 |
|
affects expression | ISO | 7 | 15,650,837 | 15,726,308 | RGD:6480464 | CTD | |
| G | MEPCE | methylphosphate capping enzyme |
|
decreases expression | EXP | 7 | 100,026,413 | 100,031,749 | RGD:6480464 | CTD | |
| G | MERTK | c-mer proto-oncogene tyrosine kinase |
|
increases expression | EXP | 2 | 112,656,191 | 112,786,945 | RGD:6480464 | CTD | |
| G | MESDC2 | mesoderm development candidate 2 |
|
affects expression | ISO | 15 | 81,268,095 | 81,282,205 | RGD:6480464 | CTD | |
| G | MESP2 | mesoderm posterior 2 homolog (mouse) |
|
affects expression | ISO | 15 | 90,319,589 | 90,321,985 | RGD:6480464 | CTD | |
| G | METRN | meteorin, glial cell differentiation regulator |
|
increases expression | EXP | 16 | 765,173 | 767,480 | RGD:6480464 | CTD | |
| G | METRNL | meteorin, glial cell differentiation regulator-like |
|
affects expression | ISO | 17 | 81,037,567 | 81,052,592 | RGD:6480464 | CTD | |
| G | METTL21A | methyltransferase like 21A |
|
decreases expression | ISO | 2 | 208,473,839 | 208,489,973 | RGD:6480464 | CTD | |
| G | METTL3 | methyltransferase like 3 |
|
multiple interactions | EXP | 14 | 21,966,282 | 21,979,457 | RGD:6480464 | CTD | |
| G | METTL6 | methyltransferase like 6 |
|
multiple interactions | EXP | 3 | 15,451,377 | 15,469,042 | RGD:6480464 | CTD | |
| G | METTL6 | methyltransferase like 6 |
|
affects expression | ISO | 3 | 15,451,377 | 15,469,042 | RGD:6480464 | CTD | |
| G | METTL7B | methyltransferase like 7B |
|
affects expression | ISO | 12 | 56,075,330 | 56,078,395 | RGD:6480464 | CTD | |
| G | MEX3A | mex-3 homolog A (C. elegans) |
|
decreases expression | EXP | 1 | 156,041,804 | 156,051,789 | RGD:6480464 | CTD | |
| G | MFAP3L | microfibrillar-associated protein 3-like |
|
affects expression | ISO | 4 | 170,907,748 | 170,947,429 | RGD:6480464 | CTD | |
| G | MFAP4 | microfibrillar-associated protein 4 |
|
decreases expression | EXP | 17 | 19,286,755 | 19,290,532 | RGD:6480464 | CTD | |
| G | MFGE8 | milk fat globule-EGF factor 8 protein |
|
affects expression | ISO | 15 | 89,441,914 | 89,456,663 | RGD:6480464 | CTD | |
| G | MFI2 | antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 |
|
increases expression | EXP | 3 | 196,728,611 | 196,756,687 | RGD:6480464 | CTD | |
| G | MFN1 | mitofusin 1 |
|
affects expression | ISO | 3 | 179,065,480 | 179,111,014 | RGD:6480464 | CTD | |
| G | MFSD1 | major facilitator superfamily domain containing 1 |
|
increases expression | EXP | 3 | 158,519,715 | 158,547,508 | RGD:6480464 | CTD | |
| G | MFSD10 | major facilitator superfamily domain containing 10 |
|
affects expression | ISO | 4 | 2,932,288 | 2,936,586 | RGD:6480464 | CTD | |
| G | MFSD2A | major facilitator superfamily domain containing 2A |
|
affects expression | ISO | 1 | 40,420,784 | 40,435,628 | RGD:6480464 | CTD | |
| G | MFSD5 | major facilitator superfamily domain containing 5 |
|
multiple interactions | EXP | 12 | 53,645,370 | 53,648,190 | RGD:6480464 | CTD | |
| G | MFSD9 | major facilitator superfamily domain containing 9 |
|
affects expression | ISO | 2 | 103,333,666 | 103,353,337 | RGD:6480464 | CTD | |
| G | MGAT1 | mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
multiple interactions | EXP | 5 | 180,217,541 | 180,237,137 | RGD:6480464 | CTD | |
| G | MGAT2 | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
affects expression | ISO | 14 | 50,087,489 | 50,090,199 | RGD:6480464 | CTD | |
| G | MGEA5 | meningioma expressed antigen 5 (hyaluronidase) |
|
decreases expression | ISO | 10 | 103,544,200 | 103,578,222 | RGD:6480464 | CTD | |
| G | MGEA5 | meningioma expressed antigen 5 (hyaluronidase) |
|
multiple interactions | EXP | 10 | 103,544,200 | 103,578,222 | RGD:6480464 | CTD | |
| G | MGLL | monoglyceride lipase |
|
affects expression | ISO | 3 | 127,407,905 | 127,542,093 | RGD:6480464 | CTD | |
| G | MGMT | O-6-methylguanine-DNA methyltransferase |
|
affects expression | ISO | 10 | 131,265,454 | 131,565,783 | RGD:6480464 | CTD | |
| G | MGP | matrix Gla protein |
|
multiple interactions | EXP | 12 | 15,034,115 | 15,038,853 | RGD:6480464 | CTD | |
| G | MGST3 | microsomal glutathione S-transferase 3 |
|
affects expression | ISO | 1 | 165,600,110 | 165,625,373 | RGD:6480464 | CTD | |
| G | MGST3 | microsomal glutathione S-transferase 3 |
|
increases expression | ISO | 1 | 165,600,110 | 165,625,373 | RGD:6480464 | CTD | |
| G | MIA3 | melanoma inhibitory activity family, member 3 |
|
increases expression | EXP | 1 | 222,791,444 | 222,841,351 | RGD:6480464 | CTD | |
| G | MIA3 | melanoma inhibitory activity family, member 3 |
|
affects expression | ISO | 1 | 222,791,444 | 222,841,351 | RGD:6480464 | CTD | |
| G | MIB2 | mindbomb E3 ubiquitin protein ligase 2 |
|
increases expression | ISO | 1 | 1,550,795 | 1,565,990 | RGD:6480464 | CTD | |
| G | MICAL3 | microtubule associated monooxygenase, calponin and LIM domain containing 3 |
|
affects expression | ISO | 22 | 18,270,415 | 18,507,325 | RGD:6480464 | CTD | |
| G | MICAL3 | microtubule associated monooxygenase, calponin and LIM domain containing 3 |
|
multiple interactions | EXP | 22 | 18,270,415 | 18,507,325 | RGD:6480464 | CTD | |
| G | MICALL1 | MICAL-like 1 |
|
increases expression | ISO | 22 | 38,302,155 | 38,338,465 | RGD:6480464 | CTD | |
| G | MICB | MHC class I polypeptide-related sequence B |
|
increases expression | EXP | 6 | 31,465,855 | 31,478,901 | RGD:6480464 | CTD | |
| G | MICU1 | mitochondrial calcium uptake 1 |
|
increases expression | EXP | 10 | 74,127,084 | 74,385,949 | RGD:6480464 | CTD | |
| G | MICU1 | mitochondrial calcium uptake 1 |
|
increases expression | ISO | 10 | 74,127,084 | 74,385,949 | RGD:6480464 | CTD | |
| G | MID1IP1 | MID1 interacting protein 1 |
|
affects expression | ISO | X | 38,660,685 | 38,665,785 | RGD:6480464 | CTD | |
| G | MIPEP | mitochondrial intermediate peptidase |
|
affects expression | ISO | 13 | 24,304,328 | 24,463,587 | RGD:6480464 | CTD | |
| G | MIS12 | MIS12, MIND kinetochore complex component, homolog (S. pombe) |
|
multiple interactions | EXP | 17 | 5,389,694 | 5,394,131 | RGD:6480464 | CTD | |
| G | MITD1 | MIT, microtubule interacting and transport, domain containing 1 |
|
affects expression | ISO | 2 | 99,785,726 | 99,797,492 | RGD:6480464 | CTD | |
| G | MITF | microphthalmia-associated transcription factor |
|
increases expression | EXP | 3 | 69,788,586 | 70,017,488 | RGD:6480464 | CTD | |
| G | MRPL50 | mitochondrial ribosomal protein L50 |
|
affects expression | ISO | 9 | 104,152,249 | 104,160,919 | RGD:6480464 | CTD | |
| G | MRPL53 | mitochondrial ribosomal protein L53 |
|
multiple interactions | EXP | 2 | 74,699,085 | 74,699,942 | RGD:6480464 | CTD | |
| G | MRPS12 | mitochondrial ribosomal protein S12 |
|
multiple interactions | EXP | 19 | 39,421,348 | 39,423,660 | RGD:6480464 | CTD | |
| G | MRPS18A | mitochondrial ribosomal protein S18A |
|
multiple interactions | EXP | 6 | 43,638,934 | 43,655,549 | RGD:6480464 | CTD | |
| G | MRPS18B | mitochondrial ribosomal protein S18B |
|
affects expression | ISO | 6 | 30,585,486 | 30,594,174 | RGD:6480464 | CTD | |
| G | MRPS2 | mitochondrial ribosomal protein S2 |
|
decreases expression | ISO | 9 | 138,392,477 | 138,396,519 | RGD:6480464 | CTD | |
| G | MRPS24 | mitochondrial ribosomal protein S24 |
|
multiple interactions | EXP | 7 | 43,906,157 | 43,909,145 | RGD:6480464 | CTD | |
| G | MRPS24 | mitochondrial ribosomal protein S24 |
|
affects expression | ISO | 7 | 43,906,157 | 43,909,145 | RGD:6480464 | CTD | |
| G | MRPS30 | mitochondrial ribosomal protein S30 |
|
decreases expression | ISO | 5 | 44,809,027 | 44,815,616 | RGD:6480464 | CTD | |
| G | MRPS5 | mitochondrial ribosomal protein S5 |
|
multiple interactions | EXP | 2 | 95,752,952 | 95,787,754 | RGD:6480464 | CTD | |
| G | MRRF | mitochondrial ribosome recycling factor |
|
multiple interactions | EXP | 9 | 125,026,882 | 125,085,743 | RGD:6480464 | CTD | |
| G | MRRF | mitochondrial ribosome recycling factor |
|
affects expression | ISO | 9 | 125,026,882 | 125,085,743 | RGD:6480464 | CTD | |
| G | MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 |
|
affects expression | ISO | 11 | 60,223,282 | 60,238,225 | RGD:6480464 | CTD | |
| G | MS4A2 | membrane-spanning 4-domains, subfamily A, member 2 |
|
affects expression | ISO | 11 | 59,856,137 | 59,865,940 | RGD:6480464 | CTD | |
| G | MS4A5 | membrane-spanning 4-domains, subfamily A, member 5 |
|
affects expression | ISO | 11 | 60,197,062 | 60,215,265 | RGD:6480464 | CTD | |
| G | MSGN1 | mesogenin 1 |
|
affects expression | ISO | 2 | 17,997,786 | 17,998,367 | RGD:6480464 | CTD | |
| G | MSH3 | mutS homolog 3 (E. coli) |
|
affects expression | ISO | 5 | 79,950,467 | 80,172,634 | RGD:6480464 | CTD | |
| G | MSH5 | mutS homolog 5 (E. coli) |
|
affects expression | ISO | 6 | 31,707,725 | 31,730,455 | RGD:6480464 | CTD | |
| G | MSI2 | musashi RNA-binding protein 2 |
|
affects expression | ISO | 17 | 55,333,931 | 55,757,299 | RGD:6480464 | CTD | |
| G | MSL1 | male-specific lethal 1 homolog (Drosophila) |
|
affects expression | ISO | 17 | 38,278,790 | 38,293,042 | RGD:6480464 | CTD | |
| G | MSL1 | male-specific lethal 1 homolog (Drosophila) |
|
decreases expression | ISO | 17 | 38,278,790 | 38,293,042 | RGD:6480464 | CTD | |
| G | MSL2 | male-specific lethal 2 homolog (Drosophila) |
|
decreases expression | ISO | 3 | 135,867,760 | 135,914,688 | RGD:6480464 | CTD | |
| G | MSLN | mesothelin |
|
affects expression | ISO | 16 | 810,765 | 818,865 | RGD:6480464 | CTD | |
| G | MSMO1 | methylsterol monooxygenase 1 |
|
affects expression | ISO | 4 | 166,248,818 | 166,264,316 | RGD:6480464 | CTD | |
| G | MSRB2 | methionine sulfoxide reductase B2 |
|
decreases expression | ISO | 10 | 23,384,427 | 23,410,942 | RGD:6480464 | CTD | |
| G | MSS51 | MSS51 mitochondrial translational activator |
|
affects expression | ISO | 10 | 75,183,337 | 75,193,319 | RGD:6480464 | CTD | |
| G | MVB12A | multivesicular body subunit 12A |
|
affects expression | ISO | 19 | 17,530,912 | 17,536,140 | RGD:6480464 | CTD | |
| G | MVB12B | multivesicular body subunit 12B |
|
decreases expression | EXP | 9 | 129,089,123 | 129,269,320 | RGD:6480464 | CTD | |
| G | MVB12B | multivesicular body subunit 12B |
|
affects expression | ISO | 9 | 129,089,123 | 129,269,320 | RGD:6480464 | CTD | |
| G | NREP | neuronal regeneration related protein |
|
affects expression | ISO | 5 | 111,065,000 | 111,312,628 | RGD:6480464 | CTD | |
| G | PCED1B | PC-esterase domain containing 1B |
|
affects expression | ISO | 12 | 47,610,052 | 47,630,443 | RGD:6480464 | CTD | |
| G | PCED1B | PC-esterase domain containing 1B |
|
decreases expression | ISO | 12 | 47,610,052 | 47,630,443 | RGD:6480464 | CTD | |
| G | RASA3 | RAS p21 protein activator 3 |
|
increases expression | ISO | 13 | 114,747,194 | 114,898,095 | RGD:6480464 | CTD | |
| G | RPL17 | ribosomal protein L17 |
|
affects expression | ISO | 18 | 47,014,851 | 47,018,935 | RGD:6480464 | CTD | |
| G | SLC52A1 | solute carrier family 52, riboflavin transporter, member 1 |
|
affects expression | ISO | 17 | 4,935,897 | 4,938,727 | RGD:6480464 | CTD | |
| G | TANGO2 | transport and golgi organization 2 homolog (Drosophila) |
|
affects expression | ISO | 22 | 20,008,631 | 20,053,447 | RGD:6480464 | CTD | |
| G | TANGO2 | transport and golgi organization 2 homolog (Drosophila) |
|
increases expression | ISO | 22 | 20,008,631 | 20,053,447 | RGD:6480464 | CTD | |
| G | VIMP | VCP-interacting membrane protein |
|
affects expression | ISO | 15 | 101,811,214 | 101,817,700 | RGD:6480464 | CTD | |
| G | ZFP64 | ZFP64 zinc finger protein |
|
decreases expression | ISO | 20 | 50,700,550 | 50,808,524 | RGD:6480464 | CTD | |
Term paths to the root
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term